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ABSTRACT
GENETIC INTERFERENCE AND RECEPTOR BIOLOGY OF NEGLECTED
INFLUENZA VIRUSES
RUNXIA LIU
2017
Influenza B virus (IBV) is an important pathogen that infects humans and causes seasonal
influenza epidemics. By using next-generation sequencing (NGS) approach, we analyzed
total mRNAs extracted from A549 cells infected with B/Brisbane/60/2008, and identified
four defective genomes in IBV with two from the polymerase basic subunit 1 (PB1)
segment and the other two from the matrix (M) segment. Each of them can potently
inhibit the replication of IBV. One derived from PB1 segment was able to interfere
modestly with influenza A virus (IAV) replication. The productions of the four defective
RNAs are not dependent on the cell types. The important initial insights into IBV
defective genomes can be further explored toward better understanding of the replication,
pathogenesis, and evolution of IBV.

The second study demonstrated that influenza D virus (IDV) is more efficient in
recognizing both human Neu5,9Ac2 and non-human Neu5Gc9Ac receptors than influenza
C virus (ICV). ICV prefers human Neu5,9Ac2 over non-human Neu5Gc9Ac. The results
reveal that IDV and ICV diverge in communicating with both O-acetyl group at the C9
position and acetyl/glycolyl groups at the C5 position in terminal 9-carbon SAs. Our
findings provide evidence that IDV has acquired the unique ability to infect and transmit

xvi
among agricultural animals that are enriched in Neu5Gc9Ac, in addition to pose a
zoonotic risk to humans only expressing Neu5,9Ac2.

Characterization of a contemporary human ICV is needed. C/Victoria/2/2012 (C/Vic)
isolated in 2012 was used in this study. Phylogenetic studies demonstrated that C/Vic is a
reassortant virus composed of segments derived from multiple ICV lineages or strains,
which evolved independently. We identified two mutations in the 170-loop of the HEF
protein around the receptor binding pocket as a possible antigenic determinant
responsible for the discrepant hemagglutinin inhibition results. C/Vic replicates more
efficiently at the cool temperature, which should be further investigated toward
elucidating the molecular determinants of temperature-dependent growth. The study on
this contemporary ICV shall aid in the further investigation of biology, evolution, and
pathogenesis of ICV.
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Chapter 1. Introduction and Literature Review
1.1 Classification of Influenza viruses
Influenza viruses are members of Orthomyxoviridae family. Influenza viruses contain a
segmented genome of single-stranded negative-sense RNA. They are a group of
respiratory pathogens that has diversified through evolution into three types: A, B, and C.
This classification is based on their distinct antigenic properties residing in two viral
structural proteins: nucleoprotein (NP) and matrix (M) protein (1980; W. R. Dowdle et al.,
1974). Recently, a new type of influenza virus with bovine as a primary reservoir,
provisionally designated influenza type D, has been described (B. M. Hause et al., 2014;
B. M. Hause et al., 2013). The major difference between influenza A/B viruses (IAV/IBV)
and influenza C virus (ICV) is that IAV/IBV possess eight segments while ICV contains
seven segments in viral particles. IAV and IBV contain two spike proteins:
Hemagglutinin (HA) and Neuraminidase (NA), while ICV possesses only one
glycoprotein, named Hemagglutinin-Esterase-Fusion (HEF) protein, which combines
both the functions of HA (receptor binding, membrane fusion) and NA (receptor
destroying).
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Table 1.1. Overview of four types of influenza viruses.

Among these influenza viruses, IAV is of most veterinary importance. Various strains of
subtypes of IAV can infect and cause severe diseases in several agricultural animal
species, as well as human populations (J. K. Taubenberger and J. C. Kash, 2010). IAVs
are divided into subtypes based on two surface proteins: the hemagglutinin (HA) and the
neuraminidase (NA). There are 18 different hemagglutinin subtypes and 11 different
neuraminidase subtypes (N. M. Bouvier and P. Palese, 2008; S. Tong et al., 2013; Y. Wu
et al., 2014).

IBV and ICV are thought to be human pathogens, despite IBV or ICV can be isolated
from swine or seals (A. D. Osterhaus et al., 2000; Z. Ran et al., 2015). IBV infection of
humans can result in clinical diseases similar to IAV, ranging from mild to severe
respiratory illness (A. S. Monto, 2008; W. Paul Glezen et al., 2013). IBV can cause high
mortality in seasonal influenza epidemics particularly in children (A. Gutierrez-Pizarraya
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et al., 2012; P. Wu et al., 2012). Two antigenic and genetic lineages (Victoria and
Yamagata lineages) co-circulated since the 1980s (I. G. Barr et al., 2010; J. A. McCullers
et al., 2004; P. A. Rota et al., 1990).

ICV usually causes mild upper respiratory diseases in humans. It has the ability in
causing severe lower respiratory illness in infants (S. Katagiri et al., 1983; Y. Matsuzaki
et al., 2006; H. Moriuchi et al., 1991). ICV were divided into six discrete lineages by
antigenic

and

phylogenetic

C/Yamagata/26/81,

analysis,

C/Kanagawa/1/76,

represented

C/Aichi/1/81,

by
C/Sao

C/

Taylor/1233/47,

Paulo/378/82

and

C/Mississippi/80 (Y. Matsuzaki et al., 2003; Y. Muraki et al., 1996; K. Sugawara et al.,
1993). ICV is distributed worldwide and and multiple genetic lineages co-circulate
globally (D. A. Buonagurio et al., 1986; A. C. Dykes et al., 1980; Y. Furuse et al., 2016;
Y. Matsuzaki et al., 2000; Y. Matsuzaki et al., 2016; H. Nishimura et al., 1987).

1.2 Structure of influenza viruses

Influenza virus is enveloped, spherical. The out layer is a lipid membrane that is taken
from the host plasma membrane when influenza virus budding from infected cells.
Influenza A viruses possess eight segments that encodes for eleven proteins. Two “Spike”
proteins hemagglutinin (HA) and neuraminidase (NA) are embedded into the lipid
membrane of influenza A and B viruses. HA and NA determine the subtype of influenza
A virus. There are 18 different hemagglutinin subtypes and 11 different neuraminidase
subtypes (N. M. Bouvier and P. Palese, 2008; S. Tong et al., 2013; Y. Wu et al., 2014).
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HA and NA are important proteins that induce host immune system to produce
internalization antibodies against the glycoprotein to prevent influenza virus infection. In
infected cells, HA gene express a single polypeptide chain HA0 with a length of
approximately 560 amino acids. HA0 is cleaved into two subunits, HA1 and HA2, which
linked with each other by disulphide bonds. Cleavage of HA0 into HA1 and HA2 is
essential for viral envelope and endosome membrane fusion during virus infection. In
influenza A and B virus the receptor-destroying activity is performed by the NA protein,
which hydrolyzes the glycosidic bond between sialic acid and galactosyl residues, help
newly made viral particle release from the plasma membrane.

Figure 1.1. Diagrammatic illustration of the influenza A virion (T. Horimoto and Y. Kawaoka,
2005)
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Ribonucleoproteins (vRNPs) complex is the core of influenza viruses. vRNPs are made
up of viral genome RNAs wrapped up around multiple copies of nucleoprotein (NP). At
the terminal ends of each viral segment is the three polymerase proteins (PB1, PB2 and
PA) complex. A very small amount of nuclear export protein (NEP) are made up of
vRNPs. M1 protein is underneath the viral lipid membrane, forms a matrix holding the
viral vRNPs (D. P. Nayak et al., 2009; D. P. Nayak et al., 2004).

M2 is another protein that is inserted in the lipid membrane of influenza virions. M2 is a
type III transmembrane protein that forms tetramers in the membrane (D. P. Nayak et al.,
2009; C. Schroeder et al., 2005). M2 acts as an ion channel, which will be open during
viral and endosomal membranes fusion. Opening the M2 ion channel acidifies the viral
core and help the virion release vRNP into cytosol. In influenza A virus, alternative
splicing of the M mRNA produces AM2 which forms a proton channel in the lipid membrane.

The expression of IBV M2 protein is produced from the primary RNA transcript of M
segment through a coupled termination and reinitiation mechanism via a UAAUG
pentanucleotide motif near M1 stop codon (C. M. Horvath et al., 1990a). ICV M2 protein
is a cleaved translation product of the full-length, colinear mRNA derived from influenza
C virus RNA segment (A. Pekosz and R. A. Lamb, 1998).

The polymerase basic protein 1-F2 (PB1-F2) of influenza A virus is expressed from a
second open reading frame (+1) of the PB1 gene (W. Chen et al., 2001; R. A. Lamb and
M. Takeda, 2001). PB1-F2 localizes at inner and outer mitochondrial membranes. PB1-
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F2 has been shown to play a role in mitochondrial morphology, cell apoptosis and upregulate polymerase activity (J. S. Gibbs et al., 2003; H. Yamada et al., 2004; D. Zamarin et
al., 2005).

There are some differences between type C influenza virus and type A and B viruses.
Genome of ICV has 7 segments, whereas genome of IAV and IBV has 8 segments. In
ICV, a hemagglutinin-esterase-fusion (HEF) protein has receptor binding, receptor
destroying (acetylesterase), and membrane fusion activities, whereas in IAV and IBV,
separate HA and NA proteins perform these functions in a cooperative fashion. Another
difference is that ICV uses Neu5,9Ac2 (N-acetyl-9-O-acetylneuraminic acid), while IAV
and IBV utilizes Neu5AC (N-acetylneuraminic acid) for viral entry (G. Herrler et al.,
1988). Both neuraminic acid derivatives are the terminal sugars in carbohydrate chains
attached to glycolipids or glycoproteins located at the cellular surface. Subtypes of
influenza A virus HA discriminate between an α2-6 and α2-3 linkage to the second
galactosyl residue, a property that (partially) explains species specificity. For example,
human IAV prefer bind to α2-6 linkage, avian IAV recognize α2-3 linkage, and swine
IAV can binds to both α2-6 and α2-3 linkages. This explains swine is a mixing vessel of
human and avian influenza virus. ICV’s HEF recognizes Neu5,9Ac2 independent of its
linkage to the next sugar. HEF in ICV has also esterase activity that cleaves acetyl from
the C9 position (G. Herrler et al., 1985). In influenza A and B virus the receptordestroying activity is performed by the NA protein, which hydrolyzes the glycosidic bond
between sialic acid and galactosyl residues.

1.3 Replication cycle of influenza viruses
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The life cycle of influenza virus can be divided into five stages: receptor-mediated
endocytosis; release viral ribonucleoprotein (vRNP) complexes; vRNA replication and
transcription, protein synthesis; transport of viral proteins and vRNA to plasma
membrane; virus assembly and release.

Figure 1.2. A schematic diagram of the influenza virus life cycle (G. Neumann et al.,
2009).

The entry of influenza virus into cells begins with HA (IAV or IBV) or HEF (ICV)
protein recognize its receptor sialic acid. HA1 and HEF1 contain receptor binding
domain, while HA2 and HEF2 contain fusion peptide. After HA or HEF bindings to its
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receptor, virus enter the host cells by receptor-mediated endocytosis and travel to late
endosome. The PH is around 5.5 at late endosome. The low PH triggers HA2 or HEF2 go
through conformational change and expose their fusion peptide. The fusion peptide insert
itself into endosome membrane and mediate viral and endosome membrane fusion.
Fusion is followed by release of viral core into cytosol where the M1 proteins are
disassemble and vRNPs are released. The low PH also opens M2 proton channel.
Opening M2 ion channel acidifies the viral core and weakens the interaction of M1 layer
with vRNPs.

The vRNPs then import into nucleus where replication and transcription take place.
vRNPs contains PB2, PB1, PA (or P3) and NP proteins. The nuclear localization
signals (NLS) of these proteins bind to the cellular import proteins then import vRNPs
into nucleus. The replication and transcription of vRNA are by RNA dependent RNA
polymerase (RdRp). RdRp is made up of three polymerase proteins: PB2, PB1 and PA
(or P3). During replication, the negative sensed vRNA are transcribed into
complementaty RNA (cRNA) which serves as a template to synthesize more vRNAs.
Meanwhile, vRNA are transcribed into messenger RNA (mRNA). mRNA is exported
into cytoplasm for translation. Newly synthesized polymerase, NP and NS1 are imported
back into nucleus to help with vRNA replication and transcription.

Late in replication cycle, the M1 and NS2 proteins bind to newly synthesized vRNPs and
help vRNP export from nucleus. The attachment of vRNPs to M1 proteins traiggers viral
budding from host cells. Budding occurs at apical side of polarized epithelial cells. HA,
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NA and M2 proteins are export on the membrane of infected cells. At the last step, NA
cleaves sialic acid residues from glycoproteins and glycolipids to help progeny viral
particle release from infected cells.

1.4 Defective interfering (DI) RNAs of influenza A virus
Defective interfering (DI) genomes are produced during the replication of almost all
viruses. DI genomes are truncated at highly variable positions, with either central or a
terminal deletion depending on the virus species (N. J. Dimmock and A. J. Easton, 2014,
2015). Early studies showed DI viruses were produced by high multiplicity-of-infection
(MOI) passages and contained a mixture of heterologous DI genome sequences (S. D.
Duhaut and N. J. Dimmock, 1998; P. A. Jennings et al., 1983). The underlying
mechanism for DI RNA formation has not been fully understood yet. However, there is
evidence indicating that a viral RNA polymerase slippage-based faulty replication
process is a likely mechanism (N. J. Dimmock and A. J. Easton, 2014). DI viruses
contain the truncated DI genome with the capacity to interfere with infectious virus
production. DI genomes has been detected in patients infected with different viruses,
indicating DIs may play a role in transmission and pathogenesis (D. Li et al., 2011; T. T.
Yuan et al., 1998).
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Figure 1.3. The production mechanism of defective interfering RNA in influenza A virus.

The existence of DI genomes in IBV has been reported in 1954 (P. Von Magnus, 1954)
and DI genomes are well known in IAV. So far, there are over 50 different species of DI
RNAs have been reported during IAV replication (N. J. Dimmock and A. J. Easton, 2015;
S. Noble and N. J. Dimmock, 1995). These DI RNAs are small in size and viral RNA
(vRNA) sensed. They possess similar or identical terminal sequences to their parental
segments but lack a major internal region. DI genomes inhibit with IAV replication by
competition with the parental full-length segments in replication, transcription, and
genome packaging (T. Odagiri and M. Tashiro, 1997). There is evidence showed that the
panhandle structure and the packaging signals are related in the segment-specific
inhibition in viral replication (A. Baum et al., 2010; T. Frensing et al., 2014; J. M.
Ngunjiri et al., 2013; M. Perez-Cidoncha et al., 2014). The DI genomes can be produced
by any segment, but almost all DI RNAs originated from the three largest polymerase
segments (N. J. Dimmock and A. J. Easton, 2014, 2015). DI RNAs compete with their
parental full-length segments at two steps. First, when DI genomes are produced in the
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nucleus, they engage the polymerase complexes so less full-length RNAs would be
synthesized. Second, DI genomes can compete their parental segments and be packaged
into budding virions to produce DI particles. DI particles are non-infectious. Their
replication needs co-infection with wildtype helper viruses. In addition, IAV-derived DI
genomes can potentially induce innate immune response (A. Baum et al., 2010; T.
Frensing et al., 2014; J. M. Ngunjiri et al., 2013; M. Perez-Cidoncha et al., 2014) and
protect cells or animals from infections of IAV, IBV, and other respiratory virues (N. J.
Dimmock et al., 2008; A. J. Easton et al., 2011; P. D. Scott et al., 2011).

Figure 1.4. Defective interfering RNAs interfere with wild-type influenza virus
replication. The competition of DI genomes with the parental full-length segments in
replication and transcription by engaging polymerase in nucleus; in packaging by out
competing their corresponding full-length segment.
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1.5 Current advances on influenza D virus (IDV)

IDV is a new genus of the family Orthomyxoviridae, initially isolated from a 15-week
old swine with influenza-like symptoms from Oklahoma in 2011 (B. M. Hause et al.,
2013). This virus possesses seven RNA segments and shows 50% protein sequence
identity to ICV, similar to the level of divergence between IAV and IBV. Evolutional
analysis showed IDV and ICV were diverged about 300 to 1200 years ago (Z. Sheng et
al., 2014). ICV is the genetically closest to IDV, but had no cross reactivity to ICV
antibodies and failed to undergo reassortment with ICV. Next generation sequencing
(NGS) analysis revealed a novel M1 splicing strategy differed from that of ICV. Crystal
structure of its HEF reveals an open receptor-binding cavity of HEF compared to that of
ICV, which explains the observed broad cell tropism of IDV (H. Song et al., 2016).
Subsequently, IDV was detected and isolated in cattle from United States, Europe
(France, Italy) and Asia (China, Japan) (C. Chiapponi et al., 2016; E. A. Collin et al.,
2015; M. F. Ducatez et al., 2015; E. Foni et al., 2017; B. M. Hause et al., 2014; W. M.
Jiang et al., 2014; S. Murakami et al., 2016). Besides swine and cattle, IDV was also
detected in small ruminants (sheep and goats) and horses from recent study (M. Quast et
al., 2015). Cattle have been proposed as the reservoirs for IDV (B. M. Hause et al., 2014)
and two distinct genetic and antigenic IDV lineages were co-circulating in cattle in
United States. IAV and IBV are more closely related to each other than to ICV and IDV.
ICV is genetically closest to IDV, with only 50% amino acids homology between each
other (B. M. Hause et al., 2013).
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1.5.1 Epidemiology and pathogenesis of influenza D virus

Influenza viruses can cause epidemics and pandemics by causing severe respiratory
disease spreading rapidly among all age groups. IAV can infect a wide variety of animals,
including human, horses, pigs, ferrets and birds (J. K. Taubenberger and J. C. Kash,
2010). Both IAV and IBV can cause substantial morbidity and mortality during seasonal
epidemics. IAV have caused several pandemics so far, such as Spanish influenza (H1N1),
outbreaks of avian H5N1 viruses in Hong Kong and the most recent H1N1 influenza
virus pandemic in 2009 (G. Neumann and Y. Kawaoka, 2015). IBV doesn’t have the
potential to cause serious pandemics due to the lack of an animal reservoir. ICV cocirculating with IAV and IBV cause local epidemics (A. Anton et al., 2011; Y. Matsuzaki
et al., 2007). ICV have been isolated from pigs, dogs and human (Y. J. Guo et al., 1983; J.
C. Manuguerra and C. Hannoun, 1992). Genetic reassorting among ICV occurs
frequently in nature and most of the circulating ICV are newly emerged reassortants (Y.
Matsuzaki et al., 2003). Co-circulation of ICV belonging to different genetic and
antigenic lineages in a small community has been documented (Y. Matsuzaki et al., 1994).
ICV usually cause upper tract infection with mild clinical symptoms, such as rhinorrhea,
cough and fever (E. Greenbaum et al., 1998). Severe lower respiratory infections to
infants and young children caused by ICV have also been reported (S. Gouarin et al.,
2008). ICV co-circulate with IAV and IBV and it is hard to distinguish the clinical
differentiation among different types of influenza virus infection (Y. Matsuzaki et al.,
2007). ICV can cause natural infection in pigs and transmit from pigs to pigs by direct
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contact. Pigs inoculated with ICV had mild respiratory clinical signs, consisting of
breathing difficulty and nasal secretion increase (Y. J. Guo et al., 1983).

IDV has been widely geographic distributed since the first IDV was reported and isolated
from pig exhibiting severe influenza-like illness in Oklahoma in 2011(B. M. Hause et al.,
2013). Detection and isolation of IDVs have been reported in diseased calves in United
Stated, China, Japan, France and Italy (C. Chiapponi et al., 2016; E. A. Collin et al., 2015;
M. F. Ducatez et al., 2015; E. Foni et al., 2017; B. M. Hause et al., 2014; W. M. Jiang et
al., 2014; T. F. Ng et al., 2015). Bovine has been proposed as the natural reservoir for
IDV. Phylogenetic analysis of IDV genome sequence revealed two distinct genetic and
antigenic

lineages

represented

by

D/swine/Oklahoma/1334/2011

(D/OK)

and

D/bovine/Oklahoma/660/2013 (D/660), which co-circulating and frequently reassort with
each another (E. A. Collin et al., 2015).

Serological investigation showed that 9.5% of surveyed swine possessed antibodies
specific to IDV indicating that this previously unidentified virus circulates in U.S. swine
(B. M. Hause et al., 2013). A recent study showed 0.6% swine sera samples collected in
2009 in Italy were positive to IDV while this number increased to 11.7% in 2015 (E. Foni
et al., 2017). It indicated IDV are circulating in Italy swine herds. Interestingly, 36.8%
nasal swabs from pigs in Guangzhou, China were tested positive to IDV (S. L. Zhai et al.,
2017). It suggested IDV could transmit in pigs in South China. Seroprevalence of IDV
was investigated in small ruminants, horses and poultry. 5.2% of sheep sera and 8.8% of
goat sera were tested positive to IDV, demonstrated sheep and goat are likely susceptible
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to IDV infection (M. Quast et al., 2015). Horse serum has also been detected with
positive antibodies against IDV (unpublished data). No IDV antibodies have been
detected in poultry including chicken and turkey so far (M. Quast et al., 2015). The
prevalence of IDV in cattle especially in calves is higher. Cattle sera collected in 20032004 from 40 selected farms in Nebraska, United States were tested positive for IDV (J.
Luo et al., 2017). In 2013, 18% of bovine sera from six states in U.S. were tested positive
to IDV using real time reverse transcription PCR and HI assay (B. M. Hause et al., 2014).
Over 90% of newborn calf sera collected in 2014 had high levels of maternal antibodies
against IDV in Nebraska cattle population (J. Luo et al., 2017). It seems calves under sixmonth old are more permissive for IDV infection and transmission. This study showed
IDV has been existing as early as 2003 and has been circulating in Nebraska cattle herds.
A nationwide distribution of IDV in cattle herds in Japan has been reported. An average
30% sera collected from 2010 to 2015 were positive in cattle, but the positivity rates
varied among regions (T. Horimoto et al., 2016). More animal species (bufflo, dairy
cattle, yellow cattle) has been reported positive to IDV in South China (S. L. Zhai et al.,
2017). In human, serological studies found 1.3% of human sera were positive to IDV and
titers are low (20-40, range) (B. M. Hause et al., 2013). Similar results were obtained
from recent serological survey in Eastern South Dakota. 1.1 % of human sera were cross
react to IDV (unpublished data). Interestingly, the positive samples were from individuals
exposed and non-exposed to livestock. This indicated IDV transmission may occur
without exposed to virus and virus infected animals. In contrast with those observations,
another study reported 91% seropositive among 35 cattle-exposed workers and 18%
seropositive for non-cattle-exposed individuals (S. K. White et al., 2016). This indicates
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that IDV has the potential transmission from cattle, the natural viral reservoir to human,
causing zoonotic risk among human population. However, ICV antibody cross-activity
with IDV could be a part reason that cause the high sera-positivity rate in this study.

Figure 1.5. Transmission model of influenza D virus. IDV utilizes bovine as natural
reservoir and is transmitted from bovine to swine as indicated by the solid line.
Antibodies specific for IDV were detected from small ruminants (Sheep and goat), horses
and human. Since no influenza D virus has been isolated from these species, the potential
transmission of IDV from bovine to small ruminants, horses and human are indicated by
dotted line.

Animals infected with IDV usually exhibit no clinical signs or mild clinical respiratory
symptoms. In some cases, IDV could cause severe pneumonia in calves which may be
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involved with secondary bacterial infection (E. A. Collin et al., 2015). From experimental
IDV infection in cattle, virus was detected in both upper and lower respiratory tracts. IDV
was efficiently transmitted in contacted cattle but not from cattle to ferret. IDV infected
cattle exhibited mild respiratory symptoms and tracheal inflammation (L. Ferguson et al.,
2016).

IDV can readily infect and transmit by direct contact with both ferrets and pigs (B. M.
Hause et al., 2013). Infection was limited to the upper respiratory tract (nasal swabs, in
nasal turbinates) and no virus was detected in trachea and lung tissue. Since ferrets are
the best surrogate animal model for human with influenza infection (J. A. Belser et al.,
2009), IDV infection could pose a potential threat to human health. In addition, IDV can
infect guinea pigs and transmit by direct contact (C. Sreenivasan et al., 2015). Virus was
detected in both upper and lower (lung) respiratory tracts but no clinical symptoms were
observed. Interestingly, IDV infection can alter the structural integrity of the respiratory
epithelium and as a result trigger a significant increase in neutrophils in the trachea of
infected animals. Virus replication dynamics and transmission in in guinea pigs are in a
good agreement with those findings obtained in native animals.

Ng et al detected IDV in calves with acute respiratory disease frequently but not in
clinically healthy animals (T. F. Ng et al., 2015). Additionally, the common pathogens,
bovine viral diarrhea virus (BVDV), bovine coronavirus (BoCV), bovine herpesvirus 1
(BHV-1) and bovine respiratory syncytial virus (BRSV), associated with bovine
respirotary disease were not detected in IDV infected sick calves. This pathological effect
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seems to suggest an etiological role of IDV in bovine respiratory disease complex (RDC).
Frequent isolations or detections of IDVs from diseased cattle in Northern America (US
and Mexico), Asia, and Europe with RDC apparently support this assumption. It is worth
mentioning that in addition to swine and cattle, small ruminants (sheep and goats) and
equine are probably additional hosts for IDV.

Taken together, IDV has the potential to infect humans, which is currently supported by
experimental infections of both human surrogate models (ferret and guinea pig) as well as
by serologic evidence of exposure to IDV among persons with occupational contact with
cattle. The widespread distribution of IDV in agricultural animals (in goat, sheep, horses)
and its interspecies movement pose a potential threat to human and agricultural health
across the globe. Currently, there is no vaccine to protect animals from IDV infection.
IDVs have antigenically evolved into multiple lineages. So the IDV vaccine research
effort in the future needs to take such antigenic drift phenomena into consideration
toward a universal vaccine targeting multiple animal species. Routine diagnosis of IDV
infection in agricultural animals can be achieved by the standard reverse transcription
polymerase chain reaction (RT-PCR) and hemagglutination inhibition assay (HI).

1.5.2 Biology of influenza D virus

IAV and IBV contain eight RNA segments with two spike proteins Hemagglutinin (HA)
and neuraminidase (NA) on the surface utilizing 5-N-acetylneuraminic acid (Neu5Ac) as
their primary receptor for virus entry. ICV and IDV possess seven RNA segments lacking
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NA. The only glycoprotein Hemagglutinin-esterase-fusion (HEF) protein combines the
functions of HA (receptor binding and membrane fusion activity) and NA (receptor
destroying). However, the esterase cleaves the O-deacetylation of the N-acetyl-9-Oacetylneuraminic acid but not α-ketosidic linkage between the sialic (N-acetylneuraminic)
acid and an adjacent sugar residue (J. N. Varghese and P. M. Colman, 1991). Both ICV
and IDV utilize 5-N-acetyl-9-O-acetylneuraminic acid (Neu5, 9Ac2) as their receptor (H.
Song et al., 2016).

In cell culture, IDV demonstrates a much broader cell tropism than ICV. In vitro cellular
tropism study shows IDV can infect several cell lines such as swine testicle (ST), MadinDarby canine kidney (MDCK), Green African monkey kidney (Marc-145), human rectal
tumor (HRT-18G) and human lung adenocarcinoma (A549) cells, while ICV replicates
only in ST and HRT cells (B. M. Hause et al., 2013). IDV infected swine testicle (ST)
cells shows typical influenza virus cytopathic effects (CPE) (B. M. Hause et al., 2014; B.
M. Hause et al., 2013). Structural modeling of HEF proteins of IDV showed a variable
receptor binding site compared to ICV (B. M. Hause et al., 2013). It possesses an
identical binding site for 9-O-acetyl group but a smaller 5-N-acetyl group binding pocket.
This indicated ICD utilize the same receptor 9-O-acetylated sialic acids as ICV. Two
variable amino acids in the 9-O-acetyl group binding site could influence binding
efficiency and affinity to its receptor which may related to the observed broader celluar
tropism of IDV. Structurally, despite the fact that the hemagglutinin-esterase-fusion
glycoprotein (HEF) of both IDV and ICV possesses an extremely similar structural fold
in communicating with the cellular receptor, IDV’s HEF has an open receptor-binding
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cavity that may accommodate diverse extended glycan moieties constituting the cellular
receptor (H. Song et al., 2016). This structural flexibility may explain why the IDV has a
broad cell tropism.

Figure 1.6. An open channel in IDV HEF receptor-binding domain. In ICV, the positively
charged Lysine (K235) and negatively charged Aspartate (D269) forms a salt bridge,
pulling 230-helix and 270-loop together (A and B). While in IDV, the amino acids at
equivalent position can’t form salt bridge, leaving an open cavity (C).

IDV has a wide range of temperature for its replication. IDV also differs from ICV in that
its replication is permissive at 37 °C. ICV replicated well at optimal temperature 33°C
while IDV replicate efficiently at both 33 °C and 37°C. Further analysis showed
differences in the fusion domain of HEF proteins between ICV and IDV (Z. Sheng et al.,
2014). The variable residues located at N- and C- terminal regions of fusion domain 1
and fusion domain 3. Since temperature affect fusion activity of HEF protein (E.
Takashita et al., 2012), the variable fusion domains of the two viruses could contribute to
the different replication temperature.
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A recent study showed IDV is most stable in high temperature and low pH (J. Yu et al.,
2017). After being treated at 53°C for 120 minutes, IDV still retained infectivity while
other influenza viruses have lost infectivity completely. After being treated at pH 3.0 for
30min, IDV lost approximately 20% of its infectivity while other influenza viruses
completely lost their infectivity. Chimeric IAV with HA and NA proteins replaced by
HEF protein of IDV can tolerant higher temperature and low pH. HEF glycoprotein plays
an important role in IDV thermal and acid stability.

1.5.3 Genomics and Evolution of Influenza D virus

IDV, like ICV, contains seven segments with negative polarity. Its overall amino acid
sequence shares approximately 50% identity with that of ICV (B. M. Hause et al., 2013).
It is most closely related to ICV with seven RNA segments, rather than to IAV and IBV
containing eight segments. However, the distance between IDV and ICV is similar to the
differences between IAV and IBV for the most of genomic segments (Z. Sheng et al.,
2014).

Sequence identity was compared between D/OK and human ICV, ranging from 69-72%
for Polymerase basic protein 1(PB1) to 29-33% for (nonstructural protein) NS segment,
with about 50% overall identity (B. M. Hause et al., 2013). PB1 is the most highly
conserved polymerase protein among influenza virus genus. Identity of PB1 amino acids
sequence is 69%-72% between the two viruses and 39%-41% between D/OK and
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IAV/IBV. PB2 and P3 protein sequences homology between D/OK and human ICV are
53% and 50%, respectively, which are lower than PB1 alignment. The Pka of polymerase
acidic (PA) proteins of IAV/IBV is approximately 5.2. Polymerase protein 3 (P3) of ICV
has a Pka of 7.2. The predicted Pka of D/OK P3 is 6.2, which is between those of
IAV/IBV and ICV.

Hemagglutinin (HA) is the major glycoprotein of IAV/IBV, and hemagglutinin-esterasefusion (HEF) protein of ICV is homologous to HA. The amino acids pairwise identity is
49% among IAV HA subtypes (S. Tong et al., 2012) and approximately 25-30% between
IAV and IBV (B. M. Hause et al., 2013). The amino acid sequence of the D/OK HEF has
53% identity to ICV, similar to the observed homology among IAV HA subtypes. ICV
and D/OK possess seven and six predicted N-linked glycosylation sites in their HEF
proteins, respectively (Z. Sheng et al., 2014). D/OK lack one predicted N-linked
glycosylation at receptor binding domain, implying different strategies for IDV to escape
antibody-mediated neutralization.

NP and M proteins are highly conserved among the members of each genus of influenza
virus, which share 85% homology (B. M. Hause et al., 2013). The homologies of NP and
M proteins are only 20-30% between different types of influenza viruses (M. Yamashita
et al., 1988). The homology of D/OK and ICV NP proteins is 38-41%. The amino acids
sequence of D/OK precursor protein P42 has 38% identity with its counterpart of ICV.
The non-structural proteins NS1 of D/OK and human ICV have only 29-33% identity,
similar to 22% homology between IAV and IBV NS1 proteins.
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A major difference among influenza viruses occurs in the matrix (M) segment with
regard to the expression of M1 and M2 proteins (P. Palese and M. Shaw, 2007). IDV
utilizes a novel coding strategy for expression of M1 and M2 proteins, differs from all
other influenza virus types. ICV and IDV utilize similar splicing strategies to produce M1
protein. The unspliced mRNA translate a precursor protein P42 which is proteolytically
cleaved into the M1’and CM2 and proteins. M1 proteins of both ICV and IDV are
translated from splicing events. In ICV, the splicing introduces a termination codon to
M1 transcript. While in IDV, it adds a second exon encoding four residues to the primary
M1 transcript (B. M. Hause et al., 2014).

The 3' and 5'-terminal ends of noncoding (NC) regions of each segment were highly
conserved in D/OK. The conserved terminal sequences show partial and inverted
complementarity which enables single-strand RNAs to form “panhandle” structures (U.
Desselberger et al., 1980). “Panhandle” structures are required for mRNA synthesis and
vRNA packaging (M. T. Hsu et al., 1987). The 3' and 5'-terminal sequences are similar to
those of ICV with only one nucleotide change at position 5 (“A” in D/OK and “U” in
ICV) from 3’terminal.

Bovine IDVs and D/OK, the two representative strains of IDV lineages, had greater than
96% identity in all segments (B. M. Hause et al., 2014). PB1 (98.9 to 99.1% identity) and
NS (98.8 to 99.2% identity) segments have highest homology, while HEF (96.7 to 99.0%
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identity) and P42 (96.9 to 99.2% identity) are most diverged. The 5’ and 3’ noncoding
regions for each segment are quite conserved between of bovine and swine IDVs.
Phylogenetic analysis showed bovine and swine IDVs clustered together and most
closely related to ICV. This indicates IDV diverged from ICV after they diverged from
IAV and IBV (B. M. Hause et al., 2014). Evolution evidence showed the divergence time
of IDV and ICV from the most recent common ancestor ranges from 334 years for PB1 to
1299 years for HE (Z. Sheng et al., 2014).

1.5.4 Hemagglutinin-esterase-fusion protein of influenza D virus

Hemagglutinin-esterase-fusion(HEF) protein is the only glycoprotein on the surface of
ICV and IDV. It contains the receptor binding domain (R), esterase domain(E) and
fusion(F) domain. Crystal structure of IDV HEF revealed E1, E' and E2 subdomains of
esterase domain and F1, F2 and F3 subdomains in fusion domain. The overall HEF
structures and the individual subdomains are quite similar between IDV and ICV. R
domains show 46.3% sequence identity. Both structural modeling and crystal structure of
HEFs of IDV and ICV reveal a broader receptor-binding site (B. M. Hause et al., 2013; H.
Song et al., 2016). Crystal structure of IDV HEF further reveals an open cavity formed by
230-helix and 270-loop at the receptor-binding site. While in ICV, a salt bridge forming
by K235 and D269 between the two secondary structures causes a closed cavity. In IDV
HEF, the two amino acids are replaced by T239 and A273, which cannot form salt bridge
interaction. Other residues that form the bottom of the receptor-binding site are similar
between the two species.
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Glycan array showed that the HEF protein of IDV binds to both 5-N-Ac and 5-N-Gc
sialic acids carrying 9-O-acetyl group. This result indicates that the open cavity of
receptor-binding site residing in the HEF protein can tolerate different modifications at
the C5 position (H. Song et al., 2016). It is consistent with the observed broader cellular
tropism of IDV (H. Song et al., 2016). Crystal structure study recently revealed that the
major interaction between HEF and the receptor analogue is derived from 9-O-Ac sialic
acid. A hydrogen bond is formed between the interaction of acetyl carbonyl oxygen of 9O-Ac sialic acid and the hydroxyl group of Y231 which is Y227 in ICV. Two hydrogen
bonds are absent in IDV due to the conserved residue Y127 in IAV and IBV changed to
F127, which is same with IBV (H. Song et al., 2016; Q. Wang et al., 2007). However,
two hydrogen bonds formed between carbonyl group of C4 and T171 ensures that the 9O-acetyl group has similar orientation with binding to ICV. Additional hydrogen bonds
formed between receptor analogue and IDV HEF are one from 5-N-acetyl group with
A172 and two from the carboxyl group of C1 with S173.

Esterase domains are most conserved. The E1, E' and E2 subdomains share 66.7%,
68.8% and 56.6% sequence identity between ICV and IDV (H. Song et al., 2016). Both
HEF

proteins

form

conserved

sialate-9-O-acetylesterase

catalytic

triad

with

S71/H369/D365 for ICV and S73/H375/D372 for IDV. The conserved receptordestroying pocket indicated IDV utilizes 9-O-acetyl sialic acid as the cellular receptor for
virus entry (B. M. Hause et al., 2013). It is reported that esterase domains of HEF
proteins are conserved in some Nidovirus, such as bovine coronavirus (BCoV), porcine
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torovirus (PToV) and bovine torovirus (BToV) as well (M. A. Langereis et al., 2009; H.
Song et al., 2016).

1.6 Summary

Influenza viruses pose a constant threat to human and animal health. Among four types of
influenza viruses, IAV and IBV infect humans and can cause severe respiratory diseases
in annual influenza epidemics, which can result up to 20,000 deaths in U.S. alone. ICV is
a ubiquitous childhood pathogen typically causing mild respiratory symptoms, in rare
cases causing severe respiratory disease in infants (S. Katagiri et al., 1983; Y. Matsuzaki
et al., 2006). IDV with bovines as a primary reservoir and amplification host can
periodically spillover to humans and other agriculture animals such as swine. Better
understanding of the replication mechanism, pathogenesis, and antigenic evolution of
influenza viruses will help develop effective vaccines and control strategies against this
important group of respiratory pathogens of humans and animals.
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Chapter 2. Identification and Characterization of Viral Defective RNA Genomes
in Influenza B Virus
Abstract
Influenza B virus (IBV) is an important pathogen that infects humans and causes seasonal
influenza epidemics. To date, little is known about defective genomes of IBV and their
roles in viral replication. In this study, by using next-generation sequencing (NGS)
approach, we analyzed total mRNAs extracted from A549 cells infected with
B/Brisbane/60/2008 virus (Victoria lineage), and identified four defective genomes in
IBV with two (PB1∆A and PB1∆B) from the polymerase basic subunit 1 (PB1) segment
and the other two (M∆A and M∆B) from the matrix (M) segment. These defective
genomes retained the terminal sequences of the relevant segments but contained
significant deletions in the central regions with each having the potential for encoding a
novel polypeptide. Significantly, each of them can potently inhibit the replication of
B/Yamanashi/166/98 (Yamagata lineage). Furthermore, PB1∆A was able to interfere
modestly with influenza A virus (IAV) replication. Finally, we presented evidence that
the productions of the four defective RNAs are not dependent on the cell types. In
summary, our study provides important initial insights into IBV defective genomes,
which can be further explored toward better understanding of the replication,
pathogenesis, and evolution of IBV.

2.1 Introduction
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Influenza viruses are classified as types A, B, and C according to their distinct
antigenic properties residing in two major structural proteins (matrix 1 and nucleoprotein)
(P. Palese and M. Shaw, 2007). Recently, a new type of influenza virus with bovine as a
primary reservoir, designated influenza type D, has been described (B. M. Hause et al.,
2014; B. M. Hause et al., 2013). Influenza B virus (IBV) is a clinically important
pathogen. It has been well established that IBVs infect humans, and cause seasonal
influenza epidemics along with IAV H3N2 and H1N1 strains (N. J. Cox and K. Subbarao,
2000; J. A. McCullers et al., 1999a; J. A. McCullers et al., 2004; A. S. Monto, 2008).
Similar to IAV, IBV can result in a spectrum of clinical diseases in humans, ranging from
mild to severe respiratory illness requiring hospitalization and medical treatment (A. S.
Monto, 2008; W. Paul Glezen et al., 2013). IBV-associated mortality has been frequently
observed in seasonal influenza epidemics particularly in children and adolescents (A.
Gutierrez-Pizarraya et al., 2012; P. Wu et al., 2012). The burden of respiratory diseases
caused by IBV, coupled with the increasing strong links between IBV and fatal infections
in humans (J. A. McCullers and F. G. Hayden, 2012; C. D. Paddock et al., 2012), calls
for an urgent need for more basic and clinical investigations of IBV.

Humans are thought to be the primary host and reservoir of IBV, although
sporadic infection episodes of IBVs have been described in seals and pigs (A. D.
Osterhaus et al., 2000; Z. Ran et al., 2015). In contrast, IAV circulates in various
mammals including humans, swine, and migratory or domestic waterfowl (P. Palese and
M. Shaw, 2007). IBV evolves at an estimated rate of 2x10-3 nucleotide substitutions per
site per year for both hemagglutinin (HA) and neuraminidase (NA) segments (N.
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Nakagawa et al., 2009; R. Nerome et al., 1998; J. Shen et al., 2009). This evolutionary
rate is approximately 2-3 times slower than those observed in IAVs. Despite the
relatively slow evolutionary rate, new antigenic variants of IBV emerge, largely driven
by genetic reassortments of co-circulating IBV strains (J. H. Lin et al., 2007; J. A.
McCullers et al., 2004; J. A. McCullers et al., 1999b). IBV has evolved into two
antigenically and genetically distinct lineages, Yamagata and Victoria (W. P. Glezen,
2014; D. Vijaykrishna et al., 2015). The antigenic diversity of IBVs has posed a
significant challenge for the selection of an appropriate strain for annual vaccine
production.

Similar to IAV, IBV contains eight negative-sense, single-stranded RNA
segments. Despite similarities in the coding strategy and viral protein expression, there
are some notable differences between these two viruses. The most striking difference lies
in the neuraminidase (NA) segment (P. Palese and M. Shaw, 2007). This segment in
IAV is monocistronic, only encoding the NA protein, while the NA segment of IBV is
bicistronic, expressing two integral membrane proteins, NA and NB. The open reading
frame of NB protein starts four nucleotides before the initiating AUG codon that directs
the NA protein synthesis. Another difference is in the polymerase basic 1 (PB1) segment.
In IBV, the PB1 segment only encodes the PB1 protein, whereas in some strains of IAV,
it codes for PB1 and a small accessory protein PB1-F2 (R. Hai et al., 2010). Recent
studies have also provided evidence that IAV’s PB1 has the capacity to synthesize PB1N40 by using alternative translation initiation strategy (H. M. Wise et al., 2009). Another
major difference between IAV and IBV occurs in the matrix (M) segment with regard to
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the expression of M1 and M2 proteins (P. Palese and M. Shaw, 2007). The M2 protein of
IAV is translated from a spliced mRNA originating from the primary M segment-derived
RNA transcript (R A Lamb et al., 1981), while the expression of IBV M2 protein is
produced from the primary RNA transcript of M segment through a coupled termination
and reinitiation mechanism, also called translational stop-start, around the sequence
encoding M1 stop codon via a UAAUG pentanucleotide motif (C. M. Horvath et al.,
1990). Moreover, in a marked contrast to the nonspliced IBV M segment, the IAV M
segment can undergo three different splicing events (R A Lamb et al., 1981) and more
than 90% of M segment-derived mRNAs are spliced transcripts (N. C. Robb and E.
Fodor, 2012). These spliced transcripts in the M and NS segments of IAV were recently
speculated for important roles in viral replication, host range, and pathogenesis (Julia
Dubois et al., 2014).

In addition to spliced transcripts, the replication and transcription of IAV
segments give rise to more than 50 different defective interfering (DI) RNAs (A. R.
Davis et al., 1980; A. R. Davis and D. P. Nayak, 1979; J. Michael Janda et al., 1979; D. P.
Nayak et al., 1982; S. Noble and N. J. Dimmock, 1995). A DI RNA is a smaller (ranging
from 200-700 nucleotides in size) viral RNA (vRNA) with similar or identical terminal
sequences to its parental segment and a large internal deletion. The competition of DI
genomes with the parental full-length segments in replication, transcription, and genome
packaging results in a segment-specific inhibition of IAV replication (T. Odagiri and M.
Tashiro, 1997). The underlying mechanism for DI RNA formation has not been fully
understood yet. However, there is evidence indicating that a viral RNA polymerase
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slippage-based faulty replication process is a likely mechanism (N. J. Dimmock and A. J.
Easton, 2014). Despite the observations that DI genomes can originate from any segment,
the general consensus is that the three polymerase segments of IAV are the primary
donors of DI RNAs (N. J. Dimmock and A. J. Easton, 2014, 2015). DI vRNAs can be
packaged into budding virions from the surface of infected cells in a way to out compete
their parental segments, leading to the formation of DI particles. DI particles containing
incomplete genomes are unable to replicate, unless the missing viral protein(s) is supplied
by coinfection with replication-competent viruses. In addition to directly interfering with
wild-type IAV replication, some DI genomes are potent inducers of the innate immune
response (A. Baum et al., 2010; T. Frensing et al., 2014; J. M. Ngunjiri et al., 2013; M.
Perez-Cidoncha et al., 2014). Recent emerging data consistently indicate that the IAVderived DI genomes can protect MDCK cells or mice from infections of IAV, IBV, and
other respiratory viral pathogens such as respiratory syncytial virus (N. J. Dimmock et al.,
2008; A. J. Easton et al., 2011; P. D. Scott et al., 2011). Furthermore, IAV DI particles
were identified in the respiratory tract of infected chickens and humans (W. J. Bean et al.,
1985; T. M. Chambers and R. G. Webster, 1987; K. Saira et al., 2013), suggesting a
potential role in viral transmission and pathogenesis.

Despite significant progress on the characterization of the DI genomes in IAV and
harnessing them for broad-spectrum antivirals, and an early description of DI genome
phenomena in IBV (P. Von Magnus, 1954), little is known about the molecular nature of
IBV DI genomes and their roles in viral replication. The investigation of DI genomes of
IBV will improve our understanding of IBV pathogenesis and host immune response,
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which may inform alternative strategies for vaccine design. A high-resolution analysis of
dynamic changes in viral gene transcription following IBV infection has not been
reported. In this study, we investigated the viral gene expression dynamics of IBV in
IBV-infected human lung epithelial A549 cells using next-generation sequencing (NGS)
approach. Specifically, we identified four defective RNAs of IBV. Among them, two
defective RNAs (PB1∆A and PB1∆B) were derived from the polymerase segment 1
(PB1). The other two defective RNAs (M∆A and M∆B) were derived from the M
segment. Interestingly, the majority of the defective transcripts were from the M segment
with M∆A being the most abundant, which is substantially different from IAVs in which
most DI transcripts are generated from the three polymerase segments. Furthermore, we
showed that these four defective vRNAs strongly inhibited IBV replication and, to a
lesser degree, IAV replication. Production of these four defective vRNAs appeared to be
independent of cell types used for cultivation of IBV. Our findings provide new insights
into IBV-specific defective genomes and further characterization of these small vRNAs
may help to better understand the biology and evolution of human IBV.

2.2 Materials and Methods
2.2.1 Cells and virus.
Human lung alveolar carcinoma epithelial cell line A549 (ATCC® CCL-185)
cells, Madin-Darby canine kidney (MDCK) cells (ATCC® CCL-34), and human Calu-3
(ATCC ® HTB-55™) maintained in Dulbecco's minimum essential medium (DMEM)
supplemented with 10% (v/v) fetal bovine serum (FBS, PAA Laboratories Inc.,
Dartmouth, MA, USA) and 100 U/ml penicillin-streptomycin (Life Technologies,
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Carlsbad, CA, USA). Influenza B/Brisbane/60/2008 virus was provided by Drs. Ruben
Donis and Xiyan Xu (Center of Disease Control and Prevention, USA). The virus was
propagated using MDCK cells at an MOI of 0.1. The cells in a T75 tissue culture flask
were allowed to reach only 60% to 70% confluency at the time of infection. The virus
inoculum was suspended in 2 ml DMEM and incubated at 37°C in 5% CO2 for 1 h.
Following infection, fresh DMEM with 0.5 µg/ml tolylsulfonyl phenylalanyl
chloromethyl ketone (TPCK)-treated trypsin (Sigma, Saint Louis, MO, USA) was added
for further incubation at 37°C in 5% CO2 for 3 days. After 3 days, the supernatant was
harvested and spun at 500 × g for 10 min at 4°C to remove the cellular debris followed by
TCID50 determination in MDCK cells. DMEM supplemented with 200 U/ml penicillinstreptomycin (Life Technologies, Carlsbad, CA, USA) and 1 µg/ml TPCK-treated trypsin
(Sigma, Saint Louis, MO, USA) was used as the virus growth medium.

2.2.2 Viral growth kinetics in A549 cells
A549 cells were inoculated with influenza B/Brisbane/60/2008 virus at an MOI of
1.0. After 1 h-incubation at 37°C in 5% CO2, the viral inoculum was removed from the
cells. Cells were washed 3 times with PBS and then fresh virus growth medium were
added. At 0, 6, 12, and 24 hpi respectively, supernatant samples were collected and used
for the determination of viral TCID50 in MDCK cells. Four independent experiments
were performed with each conducted in duplicate.

2.2.3 Cell proliferation assay
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A549 Cells (15000 cells/well) were seeded onto 96 well plates overnight. Cells
were then infected with influenza B/Brisbane/60/2008 at an MOI of 1.0. After 1-h
incubation, the cells were washed with PBS 3 times, and then replaced with fresh virus
growth medium. At 6, 12, and 24 hpi, respectively, CellTiter 96 Aqueous One Solution
(Promega, Madison, WI, USA) containing tetrazolium compound [3-(4,5-dimethyl-2-yl)5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] was
added to make MTS final concentration at 317µg/ml. After 1-hour incubation with MTS,
the absorbance was detected at 490 nm using a Synergy 2 microplate reader (Biotek,
Winooski, VT, USA). Two independent experiments were performed with each run in
triplicate. To estimate the cell numbers according to absorbance values measured for
A549 cells, the corrected absorbance values at 490nm versus cell number (from 5000 to
35000 with 5000 increments) were used to plot a regression equation with an R squared
of 0.992. Cell numbers at different time points (6, 12, 24 hpi) for control cells and virusinfected cells were calculated according to this equation.

2.2.4 Next-generation sequencing
A549 cells were infected with influenza B/Brisbane/60/2008 at an MOI of 1.0.
Total cellular RNA was isolated from mock-infected cells (0 hpi) and infected cells at, 6,
12, and 24 hpi, respectively, with TRIZOL followed by RNA purification with ethanol.
RNA quality was tested using a Bioanalyzer 2100 (Agilent, Palo Alto, CA) and then
processed for cDNA library construction by using a cDNA library prep kit (Illumina Inc.,
San Diego, CA) according to the manufacturer’s instruction. cDNA library construction
and all other procedures were conducted in Genomics Core Research Facility (GCRF) at
the University of Nebraska-Lincoln (UNL). Briefly, mRNAs were purified from the total
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RNA using oligo(dT) magnetic beads followed by fragmentation. The resultant mRNAs
were reverse transcribed to cDNAs that were subjected to an end repair process followed
by ligation to the adapters. After separation in agarose gel through electrophoresis, cDNA
fragments with a size of about 200 bp were excised, extracted, and amplified by PCR
using two primers that match the ends of adaptors. PCR-enriched samples were then
sequenced by an Illumina Genome Analyzer IIx (GA IIx) sequencer in the GCRF at UNL.
Two biological replicates were sequenced for each time point (0, 6, 12 and 24 hpi). The
eight samples were barcoded and sequenced in one lane. Each of the eight samples has
approximately 5-7 million 100-nucleotide single-end reads. All sequencing results passed
quality control. The raw reads of the eight samples were submitted to NCBI SRA
database under Biosample ID: SRS1328599.

2.2.5 Transcriptome read processing
The

raw

read

quality

was

checked

using

FastQC

(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The 5 nucleotides at the 3'
end of each read, whose sequencing qualities were low, were removed using
fastx_trimmer (http://hannonlab.cshl.edu/fastx_toolkit/index.html). GSNAP was then
used to map raw reads to human (version: GRCh37.p13) and Influenza B virus genomes
(T. D. Wu and S. Nacu, 2010). Samtools was used to index bam files and remove PCR
duplicates (H. Li et al., 2009). HTSeq was used to count the number of reads mapped to
human genes defined by the Ensemble genome database and viral genes (S. Anders et al.,
2015). The percentage of viral RNA was calculated by the equation viral mRNA
reads/total mRNA reads.
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2.2.6 RT-PCR amplification and sequencing of defective RNA genomes
A549 cells were infected with B/Brisbane/60/2008 virus at an MOI of 1.0. Total
cellular RNAs were isolated from mock-infected cells and infected cells at 24 hpi,
respectively, with TRIZOL followed by subsequent RNA purification with ethanol. The
extracted RNAs were subjected to segment-specific RT-PCRs for the amplification of
defective RNA molecules. Following electrophoresis in 1% agarose gel, amplified RTPCR

products

were

excised

and

sequenced

by

a

commercial

operator

(http://www.genscript.com/) and contigs were then assembled using IBV PB1, M, and
NS segment sequences. The GenBank accession numbers of these defective RNA
sequences are KX092351 for PB1∆A, KX092352 for PB1∆B, KX092353 for M∆A, and
KX092354 for M∆B. Inclusion of NS segment in RT-PCR amplification served as a
positive control because of a well-known splicing event originated from the NS segment.
The validation primers are shown in Table 2.1. Briefly, cDNA samples specific to PB1 or
M segments were reverse transcribed from total RNA with forward primers BPB1-1For
and BM-For (Table 2.1) that target only negative-sense vRNAs. The method to reverse
transcribe negative-sense vRNAs was described by Kawakami E (E. Kawakami et al.,
2011). Each RT-PCR product was sequenced with the same set of primers for its PCR.

To determine whether or not the observed defective genomes could be produced
from the segment-derived mRNA in the absence of active viral replication, human
embryonic kidney cells HEK293T (ATCC ® CRL-3216) were transfected, respectively,
with PB1, M, and NS segments of influenza B/Yamanashi/166/98 reverse genetics
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system (E. Hoffmann et al., 2002). At 48 h post-transfection, total RNAs were extracted
and then treated with DNase to remove residual DNA. Following the inactivation of
DNase by phenol/chloroform extraction and ethanol precipitation, the treated RNAs were
used in subsequent RT-PCR reactions with the above primers and experimental
conditions. DNA plasmids, containing PB1 or M or NS segment, harbors bidirectional
promoters (Pol I and II), which allow for the synthesis of both mRNAs (RNA polymerase
II) and negative-sense vRNAs (RNA polymerase I). The amplified products were
separated through electrophoresis in 1% agarose gel.

Table 2.1. Validation Primers used in IBV defective genome RT-PCR.

Expected
Target
Size (bp)

PB1∆A

286

Forward primer (5’-3’)

Reverse primer (5’-3’)

Name

Sequence

Positions

Name

Sequence

Positions

BPB1-

ATGAAT

22-61

BPB1-

CCAATAACC

2269-2308

1For

ATAAATC

Rev

CCATAAACA

CTTATTT

TCTTCGAAGC

TCTCTTC

TTATATGTAC

ATAGAT

CC

GTGCCC
G
PB1∆B

190

BPB1

GGAACA

∆B_L

GGAACA

1

GGCTAC
ACA

118-138

BPB1∆

GTGAGCCAT

B-R1

TGCTTTCTCA
A

2237-2256
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M∆A

206

BM-

CTTTCTT

15-50

BM-Rev

GCATAGTAA

For

AAAATG

GAAATACAG

TCGCTGT

TAAAATTGA

TTGGAG

ATTTAATGC

1094-1129

ACACAA
TTGC
M∆B

NS2

163

410

BM∆

GTTGGTT

B_L1

TGGTGG

GAAATACAG

GAAAGA

TAAAATTGA

A

ATTTAATGC

BNS2-

GCAGAA

For

GCAGAG

113-132

2-36

BM-Rev

GCATAGTAA

BNS-

CAAGAGGAT

Rev

TTTTATTTTA

GATTTGT

AATTCACAA

TTAGTCA

GCACTG

1094-1129

1060-1093

CTGGCA
AAC

2.2.7 Quantitative measurement of relative abundances of defective genomes to their
parental full-length segments.
To measure the ratios of M∆A to full-length M segment and of PB1∆A to fulllength PB1 segment, A549 cells were infected with 1.0 MOI of IBV and both clarified
supernatants and cell lysates were collected at 6, 12, and 24 hpi. Viral RNAs from
supernatant and total cellular RNAs from cell lysates were then extracted using Trizol
Reagent (Invitrogen, CA, USA) according to the manufacturer’s protocol. RNA
concentration and purity were determined by NanoDrop 1000 spectrometer (Thermo
Scientific) and 200 ng RNA was used for reverse transcription with vRNA-specific
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primers using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems,
Foster City, CA). Droplets were made and analyzed on the Bio-Rad QX200 Droplet
Digital PCR (ddPCR) system according to the Droplet Digital PCR applications guide.
The ddPCR reaction consisted of 10 ul 2x Supermix for Probes (Bio-Rad), 900 nM
primers, 25 nM probes and 8 ul cDNA into a final volume of 20ul. The primers and
probes were specifically designed to query both the truncated (via targeting junction
regions) and full-length genomes (Table 2.2). No-template controls (NTC) were included
in every run. Three separate experiments were performed with each assaying sample in
triplicate.

Table 2.2. Primers and probes used for ddPCR.
Target genes

Primers/probes

Primers/probes sequence (5’-3’)

name

PB1∆A

PB1

M∆A

M

qPB1A-For

GCTATGTTGACCCACTGGCTTC

qPB1A -Rev

GGCAGCAATTTCAACAACATTC

qPB1A -Probe

6FAM-TGCACTGTTATGGGAATAA-MGBNFQ

qPB1-FL-For

CCACCTTTGTCGGCTCCAT

qPB1-FL-Rev

AACGGCACTGAACACAACAATAA

qPB1-FL-Probe

VIC-ATCATTCAACCTAAAAGAG-MGBNFQ

qMA-For

GCAGAAAGCCCCTCAATTATTATGT

qMA-Rev

GACAGAAGATGGAGAAGGCAAAG

qMA-Probe

6FAM-TCATTCAATACCTCAGTTCT-MGBNFQ

qM-FL-For

TATGAGCCCTGTGTGAATGTGAT

qM-FL-Rev

GCAAGTAAAACTAGGAACGCTCTGT

qM-FL-Probe

VIC-CTTGTTTCTCGCATAAAG-MGBNFQ
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2.2.8 Inhibition of IBV and IAV replication by defective RNAs.
293T and MDCK cells were co-cultured at approximately 70 % confluence in 12well plates and transfected with each of indicated defective RNA plasmids (0.25 µg each)
in the context of pCAGEN vector (pCAG, positive-sense mRNA production) or
pHW2000 vector (pHW, both positive- and negative-sense RNA production), together
with an 8-plasmid IBV RGS system (0.25 µg each plasmid). Transfection system was
prepared in Trans-LT1 (Mirus) and Opti-MEM I medium according to the manufacturer’s
instructions. Culture supernatants were collected at 72 hpi and titrated in MDCK cells to
determine end-point titers (TCID50/ml). The dose-dependent effects of PB1∆A and M∆A
in interference with IBV replication were investigated under similar experimental
conditions by decreasing the amount of the defective genome plasmid used for
transfection while maintaining the same concentration of the corresponding parental
segment. Three relative ratios of the defective RNA and its parental segment plasmids: 1x,
1:1 (0.25 to 0.25 µg); 0.2x, 1:5 (0.25 to 1.25 µg); and 0.1x, 1:10 (0.25 to 2.5 µg), were
used together with seven other IBV RGS plasmids (0.25 µg each plasmid) in the
transfection/infection experiment. Three separate experiments were performed with each
conducted in triplicate.

A similar approach was used to investigate whether expression of IBV-derived
PB1∆A and M∆A defective genomes could interfere with IAV replication. Co-culture of
HEF293T and MDCK cells was transfected with an 8-plasmid IAV A/WSN/33 RGS
(0.25 µg each plasmid) in the absence or presence of different amounts of PB1∆A and
M∆A. The amount of defective RNA plasmids used was 0.25 µg, 1.25 µg and 2.5 µg,
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which resulted in three different dose groups (based on the relative ratios of the defective
RNAs and its parental segment plasmids): 1x, 1:1 (0.25 to 0.25 µg); 5x, 5:1 (1.25 to 0.25
µg); and 10x, 10:1 (2.5 to 0.25 µg). Culture supernatants were collected at 24 h posttransfection and viral TCID50/ml were measured at 6, 12, and 24 h following infection of
the MDCK cell line, respectively. DNA amount in each transfection reaction here and
above was made equivalent by adding pHW empty vector. Three separate experiments
were performed with each conducted in triplicate.

2.3 Results
2.3.1 Analysis of viral gene transcription by Next-Generation Sequencing (NGS)
To investigate IBV mRNA transcription profile and the host response to IBV
infection, we infected human lung epithelial A549 cells in duplicate with human IBV
strain (B/Brisbane/60/2008, Victoria lineage) at a multiplicity of infection (MOI) of 1.0.
IBV growth kinetics in A549 cells showed that the viral replication was detected at 6
hours post infection (hpi) at an appreciable level (101.5 TCID50/ml) and increased in a
time-dependent manner over a 24-hour period (Fig. 2.1A). At 24 hpi, approximately 98%
of cells expressed IBV-specific antigens as determined by flow cytometry-based assay
(data not shown), suggesting nearly complete infection was achieved. IBV-infected cells
and uninfected controls exhibited similar cell proliferation profiles at 6 and 12 hpi, but a
statistical significant difference in cell proliferation was observed at 24 hpi (Fig. 2.1B),
indicating virus replication exerted a time-dependent effect on the cell proliferation.
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Figure 2.1. Viral replication kinetics and proliferation dynamics of IBV infected
A549 cells. (A) Viral titer in A549 cells infected with B/Brisbane/60/2008 virus.
Supernatant samples of A549 cells infected by 1.0 MOI of IBV were collected at 0, 6, 12,
and 24 hpi. The TCID50 of each sample was evaluated in MDCK cells. Mean TCID50
(±standard deviations) from 3 independent experiments in duplicate are shown. (B) A549
cell growth in the first 24 h of infection. MTS assay in 96-well plate format was
performed at 0, 6, 12, and 24 hpi. The bars represent mean cell numbers (+standard
deviations) from 3 independent experiments in triplicate. A '*' indicates a significant
difference using student’s t-test (P<0.05).
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Total mRNAs were isolated from infected cells at 0, 6, 12, and 24 hpi and the
corresponding cDNA libraries were sequenced using Illumina-based NGS technology.
The NGS reads were then aligned to the eight segments of IBV as well as the human
genome. To measure similarities of gene expression profiles at all time points, we
calculated Pearson correlation coefficients (Pcc) distance for all pairs of samples and
constructed an Unweighted Pair Group Method with Arithmetic mean (UPGMA)
dendrogram (Fig. 2.2A). The dendrogram showed that the replicate samples of all time
points clustered together first, suggesting the variations of expression profiles between
repeats are lower than those displayed between time points. The Pcc distance of gene
expression profiles between mock cell and other time points increased over time,
suggesting cellular response to IBV infection was significantly changed. In addition,
principle component analysis was used to further calculate the variations between gene
expression profiles (Fig. 2.2B). The analysis showed that there was little variation
between repeats of the same time point, suggesting a high reproducibility of the
experiments. The gene expression profiles of 6, 12, and 24 hpi showed gradual
divergence from that of mock cell samples along principal component 1 (PC1). The 6 and
12 hpi profiles were also different from 0 hpi along PC2 while the profiles of 24 hpi have
PC2 scores similar to 0 hpi, implying the expression of some genes was altered at 6 and
12 hpi and then gradually returned to basal levels at 24 hpi.

For each sample, we obtained on average over 6 million 100-nucleotide (nt) reads
mapping to either IBV or human genome. At 6 hpi, around 2.5% of the total reads
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mapped to the viral genomic segments, while at 12 hpi, this proportion increased to 24%.
At 24 hpi, nearly 30% of the total mapped reads were derived from IBV segments (Fig.
2.2C). The observed increase in viral reads over time correlated well with a step-wise
increase in viral titers as shown in the viral replication kinetics experiment (Fig. 2.1A).
During infection, M segment-derived viral transcripts were predominant as measured by
Reads Per Kilobase of transcript per Million mapped reads (RPKM) at 12 and 24 hpi (Fig.
2.2D), followed by those of HA, NP, NA, and NS segments. The viral transcripts of the
polymerase segments (PA, PB1, and PB2) were detected with the lowest abundance.
Intriguingly, the expression of M segment-related transcripts continued to increase to 24
hpi, which was in a marked contrast to viral transcripts of all other seven segments. For
the latter, the numbers of segment-specific viral transcripts either reached a plateau at 12
hpi with negligible increase for PA, PB1, PB2, and NS segments; or slight decrease for
HA, NP, and NA segments at 24 hpi, respectively.
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Figure 2.2. Analysis of viral gene transcription by NGS. (A) Hierarchical clustering of
expression profiles. The UPGMA tree was rerooted using RNA-seq read from the two
control samples as root. The divergence of expression profiles at 0, 6, 12, and 24 hpi is
shown in the UPGMA dendrogram. Two repeats (indicated with superscript 'a' and 'b') at
each time point are shown separately. (B) Principal components analysis of host gene
expression profile divergence. IBV-induced expression differences are shown using the
first two components (PC1 and PC2) of Principal components analysis. The two repeats
at each time point are partially (6 hpi) or almost completely (0, 12, and 24 hpi)
overlapping with each other for both PC1 and PC2. Two repeats (indicated with
superscript 'a' and 'b') are shown separately. (C) The percentage of viral reads in the NGS
samples. Genome-wide total gene expression was quantified using RNA-seq. Two total
RNA samples at each time point were extracted from A549 cells infected with 1.0 MOI
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of IBV. Percentage of viral genome reads was shown, which represents the ratio of the
reads of IBV genome to total reads of genomes of Homo sapiens and IBV. (D)
Expression level changes of the eight IBV segments over time. The expression level was
displayed using reads per kilobases per million reads (RPKM).

2.3.2 Identification of defective RNA genomes from M and PB1 segments
Closer examination of the position-dependent read coverage across IBV genome
showed that M segment and, to a lesser extent, PB1 segment had a large proportion of
reads mapping to the 5' and 3' ends of segments, with a significant reduction in the
number of reads mapping to the central regions (Fig. 2.3).
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Figure 2.3. Positional sequencing depth of IBV gene segments over time. Panels A-H
show positional sequencing depth for segments PB2, PB1, PA, HA, NP, NA, M, and NS,
respectively. The sequencing depth for each segment is shown as RNA-seq read counts at
each position (5'→3'). Two replicates from each time point (0, 6, 12 and 24 hpi) are
shown separately.

The overrepresentation of sequencing reads in the 5' and 3' ends of the segments
suggested the presence of internal deletions in transcripts of these genes. This observation
prompted us to search for junction reads that were mapped to two discontinuous regions
of each segment toward better understanding of the origin of these RNA molecules.
Analysis of NS segment-associated junction reads was included in this study because NS
segment is known to utilize a splicing mechanism to produce NS2 mRNA. To remove
sequencing noises, we only focused on junction sites that were supported by more than
200 reads. In the NS segment, we observed a splicing junction site between genomic
positions 80 and 763 (nts 45-80 joined to 763-1071) with sequencing coverage of more
than 1000 reads, matching the previously reported splicing donor and acceptor sites for
the NS2 transcript (D. J. Briedis and R. A. Lamb, 1982) (Fig. 2.4A). Further analysis
showed that this splicing event utilized a consensus dinucleotide motif GT/AG: GT
present at the extreme 5' (donor) and AG at the extreme 3' (acceptor) ends of the intron.
In addition, we identified two splicing-like junction sites in the PB1 segment that joined
genomic positions 116 with 2118, and 240 with 2190, respectively, which resulted in the
production of two previously uncharacterized small transcripts, PB1∆A and PB1∆B (Fig.
2.4B). Moreover, two splicing-like junction sites in the M segment that joined genomic
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positions 95 with 1005, and 199 with 1054, respectively, were also observed (Fig. 2.4C).
Further analysis indicated that none of the junction sites observed in PB1 and M
segments conformed to the canonical splicing donor and acceptor dinucleotide motif
GT/AG that are present in the splicing sites of human and influenza viral genes (N. Sheth
et al., 2006). Follow-up Reverse transcription polymerase chain reaction (RT-PCR) and
Sanger sequencing experiments confirmed the presence of NS2, PB1∆A, PB1∆B, M∆A,
and M∆B mRNAs in virus-infected A549 cells (Fig. 2.4D). Specifically, with primers
corresponding to terminal sequences of the segment (Table 2.1), we amplified nearly fulllength PB1∆A and M∆A with the identical junction site sequences as determined in
RNA-Seq (Figs. 2.4B-C). For PB1∆B and M∆B, following the initial failure in PCR
amplification with these terminal primers (Table 2.1), the revised PCRs with forward
primer sequences (Table 2.1) specific to the junction regions of PB1∆B and M∆B
successfully amplified PB1∆B and M∆B (Fig. 2.4D). The junction site position for M∆B
determined by RT-PCR coupled with Sanger sequencing was identical to that measured
in RNA-Seq experiment. We have only noted one discordance in the junction site
position for PB1∆B determined between NGS and conventional RT-PCR and Sanger
sequencing methods. In RNA-Seq, the junction site position for PB1∆B was 240/2190,
while RT-PCR and Sanger sequencing determined the junction sites for PB1∆B to be
240/2189, which was chosen for cloning of PB1∆B plasmids that were used in functional
studies below.

Based on the well-documented literature on IAV DI RNAs (A. R. Davis et al.,
1980; A. R. Davis and D. P. Nayak, 1979; N. J. Dimmock and A. J. Easton, 2015; J.
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Michael Janda et al., 1979; D. P. Nayak et al., 1982; N. Sheth et al., 2006) plus that none
of the detected junction sites for the four small transcripts is consistent with the GT/AG
splicing motif, we speculated that these small transcripts were not derived from mRNA
splicing, instead, they are likely to be viral RNA polymerase-dependent products. To test
the hypothesis, we transfected each of the three segments (PB1, M, and NS) to HEK293T
cells separately using a vector containing a CMV promoter, and extracted total RNAs
from transfected cells. We then used RT-PCR to detect PB1∆A and M∆A with same sets
of PCR primers and PCR conditions we used to detect them in virus-infected cells (Fig.
2.4D). The NS2 transcript was detected, indicating that the NS2 splicing event occurred
independent of viral replication, a bona fide splicing-derived transcript (Fig. 2.4E). In a
marked contrast, neither of the two transcripts (PB1∆A and M∆A) was detected,
indicating that their synthesis needs active viral replication. These data support the
speculation that these PB1 segment- and M segment-specific small transcripts are
produced by viral RNA polymerase-driven transcription.
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Figure 2.4. Alternative splicing or junction sites and defective RNA genomes. (A) NS
segment splicing. Diagram showing the known splicing site in IBV NS segment that
generates NS2 mRNA. (B) PB1 segment-derived defective RNAs. Schematic diagram
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shows the two newly identified defective RNAs from PB1 segment termed as PB1∆A,
and PB1∆B. (C) M segment-derived defective RNAs. Schematic diagram displays the
two newly identified defective RNAs in the M segment termed as M∆A and M∆B. The
initiation, junction, and termination positions (5'→3') of an mRNA’s ORF are labeled
with position numbers above. An mRNA’s two junction sequences are shown under
ORFs. (D) Detection of PB1∆A, M∆A, PB1∆B, M∆B and NS2 RNAs in IBV infected
A549 cells. Segment-specific primers were used to amplify full-length PB1∆A, M∆A,
and NS2 by RT-PCR. Junction-specific primers (forward) and segmental primers (reverse)
were used to amplify partial PB1∆B and M∆B transcripts. The cDNA was generated
from total mRNA extracted from IBV-infected A549 cells. (E) Absence of PB1∆A and
M∆A RNAs in HEK293T cells transfected with plasmid DNA encoding IBV PB1 and M
segment. Segment-specific primers were used to amplify PB1∆A and M∆A by RT-PCR.
NS2-specific RT-PCR was performed as a splicing control. The cDNA was generated
from total mRNA extracted from transfected HEK293T cells with IBV PB1, M, or NS
segments.

2.3.3 Abundances of Defective RNAs
We then used the RNA-Seq data to determine the transcription dynamics of
defective RNAs in influenza B virus-infected A549 cells (Fig. 2.5A). We estimated the
relative transcription levels of defective RNAs by calculating the number of junction
reads per million mapped reads. The analysis showed that the levels of PB1∆A and
PB1∆B were very low at 6 hpi, and reached peak levels at 24 hpi. Similar to PB1∆A and
PB1∆B, M∆A and M∆B levels reached the highest at 24 hpi (Fig. 2.5A). Interestingly,
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the transcription level of M∆A was over 100-fold higher than M∆B. The positional read
coverage at the M∆A junction sites was about 70-fold higher than that in the central
region of M segment, which is largely from M1 and M2 transcripts. This suggested that
the transcription level of M∆A was significantly higher than these of M1 and M2.

We next developed vRNA-sense reverse transcription (E. Kawakami et al., 2011)
coupled with two-color probe Droplet Digital PCR (ddPCR) assay that enabled us to
measure the relative abundance of the observed defective vRNAs to their parental
segments in both intracellular and extracellular (virus particles) environments. Such an
assay also allowed us to detect transcripts derived only from vRNA-sense, not from
mRNA and cRNA forms. We selected M∆A and PB1∆A as focused defective species
here and during the rest of the study. As shown in Figs. 2.5B and 2.5C, our quantitative
data showed that M∆A (Fig. 2.5B) tended to be much more abundant relative to its
parental segment than PB1∆A (Fig. 2.5C) in both infected cells and virus particles at
different time points following viral infection. M∆A was nearly 200-fold and 300-fold
more abundant than the full-length M segment in infected cells and purified virus
particles at 24 hpi, respectively (Fig. 2.5B). In marked contrast, PB1∆A only exhibited
about 1.25 to 1.75-fold increase in copy numbers over the full-length PB1 in both
infected cells and virus particles at this time point (Fig. 2.5C). Significantly, our
quantitative analysis on abundance of IBV defective vRNA transcripts correlated well
with our RNA-Seq analysis of the mRNA profile (Figs. 2.2D and 2.5A). The results of
these experiments provided evidence for the existence and the abundance of the negativesense defective genomes, which are correlated with the level of virus replication.
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Figure 2.5. Transcription profiles of defective RNAs and their relative abundances.
(A) Transcription profiles of defective mRNAs. RNA-seq junction reads for the four
defective RNAs (M∆A, M∆B, PB1∆A, and PB1∆B) and NS2 are shown as junction reads
per million total reads at indicated time points following IBV infection of A549 cells. (B)
Ratio of M∆A vRNAs relative to full-length M vRNAs. (C) Ratio of PB1∆A vRNAs
relative to full-length PB1 vRNAs. Ratios of M∆A to full-length M segment and of
PB1∆A to full-length PB1 segment were measured respectively by ddPCR. Both clarified
supernatants and cell lysates of A549 cells infected with 1.0 MOI of IBV were collected
at 6, 12, and 24 hpi. Total RNAs were then extracted and 200 ng RNA was used for
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reverse transcription with vRNA-specific primers. ddPCRs were conducted with primers
and probe specific to amplify defective RNAs (the junction regions) and full-length
segments. No-template controls (NTC) were included in every run. The ratios of
defective genomes to their corresponding full-length segments were normalized and
shown as mean±SEM (standard error of the mean) from three separate experiments with
each assaying sample in triplicate.

It should be noted that we have also investigated whether the viral inoculum
contained these defective vRNAs. Using the same vRNA-sense RT-PCR coupled with
the Sanger sequencing method, we found that viral inoculum contained PB1∆A and M∆A,
which is in good agreement with the above data, showing that PB1∆A and M∆A vRNAs
can be packaged into budding viral particles. These results demonstrated that defective
vRNAs such as M∆A and PB1∆A required active IBV replication. The presence of both
M∆A and PB1∆A in viral particles suggested that these short forms were incorporated
into budding virions during viral morphogenesis.

2.3.4 Inhibition of IBV and IAV replication by defective vRNAs
It is known that vRNA-sense DI genomes of IAV are required to inhibit virus
replication (Y. Boergeling et al., 2015; T. Odagiri and M. Tashiro, 1997). To determine
whether the four defective genomes (M∆A, M∆B, PB1∆A, and PB1∆B) were able to
interfere with the replication of IBV, we placed each individual defective sequence into
the pHW2000 (pHW) vector with bidirectional promoters (Pol I and II) that allow both
RNA polymerase I transcription of vRNAs and RNA polymerase II-driven transcription
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of mRNAs. As such, we generated a set of control plasmids in the pCAGEN (pCAG)
vector that just contains a pol II promoter (chicken ß-actin) so only mRNAs are
transcribed. To test the effects of vRNA-sense defective genome transcription on virus
replication, we employed a transfection-based reverse genetics system (RGS) to generate
B/Yamanashi/166/98 virus (E. Hoffmann et al., 2002) in the presence or absence of
defective genomes (1x, 1:1 ratio of defective genome and the corresponding parental
segment plasmids), viral infectivity was then determined to measure the defective RNAs’
effects. As shown in Fig. 2.6B, IBV replication was completely inhibited in the presence
of either defective genome derived from the pHW vector, as robust virus replication was
only detected in the empty vector control (mock). In contrast to the halted replications by
the pHW series, the replication levels were not much affected by the pCAG series (Fig.
2.6). The only noticeable inhibition by the pCAG series was approximately 1-log
reduction in the pCAG-PB1∆A (Fig. 2.6A).

This moderate inhibition by the

transcriptions of PB1∆A mRNA may indicate a role of a novel polypeptide from this
specific defective transcript in viral replication, which should be investigated in future
study. Overall, our activity data suggested that the presence of each of the four defective
transcripts in vRNA form, but not in mRNA form, is sufficient to inhibit IBV viral
replication.

To further investigate the dose-dependent effects of the defective vRNA-induced
interference with IBV replication, we decreased the amount of the pHW-vectored
plasmids used for transfection while maintaining the same concentration of the
corresponding parental segment. Three relative ratios of the plasmids carrying defective
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genome sequences to the plasmids carrying parental segment sequences (1x, 1:1; 0.2x,
1:5; and 0.1x, 1:10) were used together with seven other IBV RGS plasmids in the
transfection/infection experiment. Dose-dependent suppression of IBV replication by
PB1∆A or M∆A was nicely demonstrated in Figs. 2.6C and 2.6D. Specifically, PB1∆A or
M∆A, when used in equal amount as its parent segment plasmid (1x group), completely
inhibited IBV replication (Figs. 2.6C and 2.6D), which was similar to our previous data
(Fig. 2.6B). Reducing the amount of DI plasmid by 80% relative to the corresponding
full-length segment plasmid (0.2x group) resulted in a moderate reduction (around 1.0 log) of viral infectivity when compared to controls (pHW vector and mock transfections).
Furthermore, there was no detectable reduction in viral infectivity observed in 0.1x group
where the PB1∆A (Fig. 2.6C) or M∆A DI (Fig. 2.6D) plasmid for transfection was
further reduced by 90% relative to the full-length segment plasmid.

Figure 2.6. Inhibition of IBV replication by defective RNAs. Co-culture of HEK293T
and MDCK cells were transfected with each of indicated defective genome plasmids
(0.25 µg each) in the context of (A) pCAG vector (positive-sense mRNA production) or
(B) pHW vector (both positive and negative-sense RNA production), together with an 8-
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plasmid IBV RGS system (0.25 µg each plasmid). Culture supernatants collected at 24
hpi were titrated in MDCK cells to determine end-point titers (TCID50/ml). The dosedependent effects of PB1∆A and M∆A genomes in interference with IBV replication
(Panels C and D) were investigated under similar experimental conditions by decreasing
the amount of the defective genome plasmid used for transfection while maintaining the
same concentration of the corresponding parental segment. Three relative ratios of the
defective genome and parental segment plasmids: 1x, 1:1 (0.25 to 0.25 µg); 0.2x, 1:5
(0.25 to 1.25 µg); and 0.1x, 1:10 (0.25 to 2.5 µg), were used together with seven other
IBV RGS plasmids (0.25 µg each plasmid) in the transfection/infection experiment. The
data are showed as mean±SEM (standard error of the mean) from three separate
experiments in triplicate each. One-way ANOVA is used to calculate significance with
one star indicating p<0.05 and two stars indicating P<0.01, respectively.

Next, we investigated whether expression of IBV-derived PB1∆A and M∆A
defective genomes could interfere with IAV replication using a similar approach as
described above. For determining viral infectivity, indicator of defective RNAs’ effects,
we measured viral TCID50/ml at 6, 12, and 24 h following infection of the MDCK cell
line, respectively. Similarly, three different dose groups (based on the relative ratios of
the defective genome and its parental segment plasmids) were used in this experiment,
which were 1x, 1:1 (0.25 to 0.25 µg); 5x, 5:1 (1.25 to 0.25 µg); and 10x, 10:1 (2.5 to 0.25
µg). As demonstrated in Fig. 2.7, IAV replication was not overall substantially inhibited
by either M∆A or PB1∆A when used in the same amount of plasmid DNA as the
corresponding full-length M or PB1 segment (1x group).

Interestingly, significant

73
inhibitions of IAV replication were achieved when PB1∆A plasmid was used 5 (5x group)
or 10 times (10x group) higher than its parental PB1 segment (Fig. 2.7A). For example,
in 10x group, no detectable viruses were found in the presence of PB1∆A at 6, 12 and 24
hpi. In the 5x group, introduction of PB1∆A resulted in a complete inhibition of IAV
replication at 6 hpi followed by nearly 3-log and around 1-log reductions relative to mock
vector control at 12 and 24 hpi, respectively (Fig. 2.7A). In a marked contrast, increasing
the quantity of transfected M∆A plasmid showed no significant inhibitory activity against
IAV (i.e., 5x and 10x group) over the course of this experiment (Fig. 2.7B).

Figure 2.7. Inhibition of IAV replication by defective RNAs. Co-culture of HEF293T
and MDCK cells was transfected with an 8-plasmid A/WSN/33 RGS in the absence or
presence of different amounts of PB1∆A (Panel A) and M∆A (Panel B). Note 1x: 0.25 µg
defective RNA plasmid and 0.25 µg of each of RGS plasmids, 5x: 1.25 µg defective
RNA plasmid and 0.25 µg of each of RGS plasmids, and 10x: 2.5 µg defective RNA
plasmid and 0.25 µg of each of RGS plasmids. DNA amount in each transfection reaction
was made equivalent by adding pHW empty vector. Culture supernatants collected at 6,
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12, and 24 hpi were titrated for determining viral infectivity (TCID50/ml) in MDCK cells.
The data are showed as mean±SEM (standard error of the mean) from three separate
experiments in triplicate each. One-way ANOVA is used to calculate significance with
one star indicating p<0.05 and two stars indicating P<0.01, respectively.

In summary, the above experimental data demonstrated that all four defective
genomes (PB1∆A, PB1∆B, M∆A and M∆B) identified from our NGS data potently
inhibited IBV replication. Further investigation of PB1∆A and M∆A showed that PB1∆A,
not M∆A, was able to interfere with IAV replication but the degree of inhibition was less
pronounced when compared to that observed for IBV.

2.3.5 Cell type-independent phenomenon of IBV defective genomes production.
Finally, we were interested in determining whether the cell type played a decisive
role in the production of the observed PB1∆A, PB1∆B, M∆A, and M∆B defective
genomes (Fig. 2.8). In addition to the A549 cell line, we included Madin Darby Canine
Kidney (MDCK) and human epithelial lung Calu-3 due to the following considerations.
Firstly, MDCK cell line has been a constant source to study DI genomes of IAV.
Secondly, Calu-3 is another relevant epithelia cell line to investigate the biology of
influenza viruses. Total RNAs were extracted from viral supernatants collected at 24 hpi
with 1.0 MOI of influenza B/Brisbane/60/2008, which was then followed by defective
genome-specific RT-PCR amplification. After the agarose gel electrophoresis of RT-PCR
products, the DNA bands of correct sizes were excised, purified and sequenced toward
the identification of junction sites. As demonstrated in Fig. 2.8, all four defective
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genomes with the expected correct junction site were produced in the three tested cell
lines, which suggested a cell type-independent mechanism for IBV defective genomes
production.

Figure 2.8. Cell type-independent production of IBV defective genomes. A549, Calu3, and MDCK cells were infected, respectively, with 1.0 MOI of B/Brisbane/60/2008.
Total RNAs were extracted from viral supernatants collected at 24 hpi, which was then
followed by defective genome-specific RT-PCR amplification. After the agarose gel
electrophoresis of RT-PCR products, the DNA bands of correct sizes were excised,
purified and sequenced through the Sanger method toward the identification of junction
sites. The data shown are representative of three independent experiments.

2.4 Discussion
DI genomes have been well described in natural IAV infections (A. R. Davis et al.,
1980; A. R. Davis and D. P. Nayak, 1979; N. J. Dimmock and A. J. Easton, 2014, 2015;
N. J. Dimmock et al., 2008; J. Michael Janda et al., 1979; D. P. Nayak et al., 1982; K.
Saira et al., 2013). Despite earlier studies showing that DI genomes can arise from any of
the eight segments during viral replication, it is generally agreed upon that the three
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largest polymerase segments (PA, PB1, and PB2) are the primary donors generating these
DI RNAs in cell cultures as well as in infected animals (N. J. Dimmock and A. J. Easton,
2014, 2015; K. Saira et al., 2013). The transmission of DI genomes has occurred between
human patients infected with influenza A (H1N1) pdm09 virus (K. Saira et al., 2013).
Because the position of the internal deletion is highly variable in the segment, a
heterogeneous population of segment-specific DI genomes has been frequently observed
in IAV-infected cells and animals (N. J. Dimmock et al., 2008; K. Saira et al., 2013). To
date, more than 50 different species of DI RNAs have been described in IAV-infected
cells (N. J. Dimmock and A. J. Easton, 2015; S. Noble and N. J. Dimmock, 1995).
Although IBV DI phenomena has been reported in 1954 (P. Von Magnus, 1954), and the
presence of substantial amount of putative IBV DIs in addition to IAV DIs in live
attenuated influenza vaccine has been described recently (P. S. Gould et al., 2017), their
roles in moderating viral replication and establishing host protective immunity is not
clear.

Here we demonstrated that IBV, like IAV, is capable of producing defective
genomes during viral replication. Specifically, by NGS coupled with RT-PCR and
traditional Sanger sequencing, we have confirmed the presence of four defective genomes
in A549 human lung epithilial cells that had been infected with B/Brisbane/60/2008. The
stringent threshold (i.e., above 200 junction reads) employed in our sequence analysis
may result in the detection of a relatively low number of defective genomes in IBVinfected A549 cells. An alternative explanation is our experimental conditions where no
continuous virus passage or high infectious dose was employed (only 1 MOI used in this
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study). Regardless of a precise cause, our data indicated that both PB1 and M segments
likely serve as a major source for the production of defective RNAs upon IBV infection.

Each of the identified four defective genomes (PB1∆A, PB1∆B, M∆A, and M∆B),
when transcribed into vRNA-sense, was able to potently inhibited the replication of IBV.
The interfering activities of the defective genomes we had seen are similar to these of the
well-characterized IAV DI genomes. Therefore, we propose that the four defective
genomes should be categorized as DI genomes. Despite their unknown mechanism of
action, by analogy with IAV, one can envision that the defective vRNAs inhibit the
growth of IBV by competing with their corresponding full-length segment for the
engagement of the viral polymerase complex during replication of vRNA into cRNA as
well as for the final packaging into budding virus particles. Interestingly, only PB1∆A
had the ability to exert a moderate and dose-dependent interference effect, which was
much less pronounced than that seen in the interference of cognate IBV replication (Figs.
2.6 and 2.7). Because PB1 is the most conserved vRNA segment between IAV and IBV,
we speculate that the PB1 segment shares more similar features such as the panhandle
structure (vRNA promoter for viral RNA polymerase complex formed by the 5’ and 3’
termini of each segment) and the packaging signal sequence (containing the 5’ and 3’
non-coding regions and the terminal coding sequences of each segment) than the M
segment between IAV and IBV. Previous studies have shown that the panhandle structure
and the packaging sequence play a decisive role in DI-mediated interference in viral
replication (A. Baum et al., 2010; T. Frensing et al., 2014; J. M. Ngunjiri et al., 2013; M.
Perez-Cidoncha et al., 2014). The sequence and structural differences between IBV PB1
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and M segments, probably subtle, warrant further investigation toward addressing the
mechanism by which DI RNA from IBV PB1, not M segment, interfere with IAV
replication.

Presence of the highly abundant M∆A (i.e., 200-fold and 300-fold higher than the
parental M segment, Fig. 2.5B) in both virus-infected cell and virus particles raised
several interesting questions. First, the observed high abundance of M∆A in virus
particles provides evidence that the majority of influenza B virions lacks the full-length
parental M segment and are thus incapable of conducting autonomous replication.
Overproduction of IBV M segment-derived DI genome may represent a major source that
derives high particle-to-PFU (plaque formation unit) ratio as normally seen in animal
viruses such as influenza A virus. Second, the presence of a predominant M segmentderived defective genome during active IBV replication may further discriminate IBV
from IAV in defective genome production and M segment-centered expression strategy.
Numerous studies of IAV have shown that the three polymerase segments, not the M
segment, are the major forces driving the generation of DI genomes (A. R. Davis et al.,
1980; Philip A. Jennings et al., 1983; S. Noble and N. J. Dimmock, 1995; K. Saira et al.,
2013). Moreover, the M2 protein of IAV is translated from M2 mRNA, which is
generated via alternative splicing (R A Lamb et al., 1981). However, IBV’s M segment
depends on a translational stop-start strategy to synthesize BM2 protein (C. M. Horvath
et al., 1990). To our knowledge, no splicing event has been previously observed in IBV
M segment. Intriguingly, the M segment in IAV is favored for splicing because three
independent splicing events have been identified, while its counterpart in IBV is largely
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selected for producing defective genomes. Further dissection of this notable difference
may help us better appreciate the differences between these two closely related influenza
viruses in biology and evolution. Third, why does IBV replication give rise to such
abundant M∆A species? It can be assumed that M∆A is a perfect vRNA template that can
be recognized and replicated efficiently by the viral RNA polymerase complex. This
situation, if true, may consume substantial energy and resources, which, the viral
replication machinery could otherwise save for manufacturing more infectious viral
particles for subsequent infection. Alternatively, it can be proposed that M∆A abundance
is intentionally required for efficient IBV replication and transmission. For example, it
may behave as an accessory factor to facilitate viral replication or help IBV-infected cells
recover from apoptosis or damage. Paradoxically, this model should reconcile the
prevailing dogma that DI is a negative regulator of viral replication by competing out its
full-length segment. An emerging role for DI such as antiviral innate immune response
inducer should be also taken into consideration to address the potential opposing effects
of DI in modulation of IBV replication in vitro and in vivo (A. Baum et al., 2010; T.
Frensing et al., 2014; J. M. Ngunjiri et al., 2013; M. Perez-Cidoncha et al., 2014).
Furthermore, excessive production of the defective genomes such as M∆A may allow
IBV to employ it as a decoy molecule in misleading the anti-IBV innate response to help
IBV evade immune recognition toward efficient replication and transmission in humans,
which shall be invested in further studies.

Our studies also demonstrated that all four defective genomes initially found in
infected A549 cells were also present in two other cell types, MDCK and Calu-3. This
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result indicated that cell type might not have a direct role in IBV-specific defective
genomes diversity. Despite decades of research, the molecular mechanism underlying DI
RNA formation has not been fully elucidated. Current studies suggest that a viral RNA
polymerase slippage-based faulty replication process is a likely mechanism (N. J.
Dimmock and A. J. Easton, 2014). Heterologous populations of DI present in IAV and
various species of segment-derived DIs in terms of the junction sites support this model.
Our observation of over-abundant M∆A in IBV, however, may challenge this model. It
will be interesting to address whether defective RNA production especially M∆A, is a
specific mechanism or due to the viral RNA polymerase slippage-based faulty replication
that often occurs randomly. In summary, we identified four DI genomes specific to IBV
replication, with M segment-derived M∆A being the most abundant. The negative-sense
defective vRNAs potently inhibit the replication of B/Yamanashi/166/98. PB1∆A was
able to modestly interfere with IAV replication. In addition, the productions of the four
DIs are independent of cell types. Further characterization of these DI genomes should
advance our understanding of the biology and evolution of IBV.
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Chapter 3. Influenza D virus diverges from its related influenza C virus in the
recognition of 9-O-acetylated N-acetyl- or N-glycolyl- neuraminic acid-containing
glycan receptors

ABSTRACT
Novel influenza D virus (IDV) utilizes cattle as a primary reservoir with
periodically spillover to other mammalian hosts including pigs and horses. Viral
attachment to terminal sialic acids (SAs) of sialoglycans exposed on the cell surface is a
determinant of tissue tropism and host range. Using the hemagglutination assay, we
demonstrated that IDV, like its related influenza C virus (ICV), utilized 9-O-acetylated
N-acetylneuraminic acid (Neu5,9Ac2) for attachment to Turkey red blood cells (RBCs)
and 9-O-acetylation group was a critical SA receptor determinant of IDV. Furthermore,
with the sialylated glycan microarray (SGM), we found that IDV also interacted with 9O-acetylated N-glycolylneuraminic acid (Neu5Gc9Ac) equally well, while ICV preferred
Neu5,9Ac2 over Neu5Gc9Ac. Finally, the glycan array data were supported by functional
studies showing that both Neu5,9Ac2 and Neu5Gc9Ac receptor analogs exhibited a dosedependent inhibition of IDV replication as well as its ability to agglutinate RBCs. Similar
results were obtained for ICV but the inhibition levels were much less pronounced with
relatively more inhibition of ICV replication and attachment to RBCs by Neu5,9Ac2 than
Neu5Gc9Ac. Neu5Gc9Ac is different from Neu5,9Ac2 only by an additional oxygen
atom at the C5 position. The results of our experiments reveal that IDV and ICV diverge
in communicating with both O-acetyl group at the C9 position and acetyl/glycolyl groups
at the C5 position in terminal 9-carbon SAs. These findings will provide a framework for
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further investigation towards better understanding of how newly found multiple-speciesinfecting IDV exploits natural 9-O-acetylated SA variations to expand its host range.

IMPORTANCE
Influenza D virus (IDV) utilizes cattle as a primary reservoir. Recently increased IDV
outbreaks in pigs and serological evidence of IDV infection in humans have raised a
concern about the potential of IDV adapting to humans. Viral attachment to terminal
sialic acids on the cell surface serves as a first determinant of tissue tropism and host
range. Our studies demonstrate that IDV is more efficient in recognizing both human
Neu5,9Ac2 and non-human Neu5Gc9Ac receptors than ICV, a ubiquitous human
pathogen. ICV seems to strongly prefer human Neu5,9Ac2 over non-human Neu5Gc9Ac.
Humans cannot make Neu5Gc9Ac due to frame-shift mutations occurring in the CMPNeu5Ac hydroxylase (CMAH) that synthesizes Neu5GC, the substrate of the
Neu5Gc9Ac. Our findings provide evidence that IDV has acquired the unique ability to
infect and transmit among agricultural animals that are enriched in Neu5Gc9Ac, in
addition to pose a zoonotic risk to humans only expressing Neu5,9Ac2.

3.1 Introduction

The Orthomyxoviridae family has three influenza genera, A, B, and C, which are
classified according to antigenic differences in their nucleoprotein (NP) and matrix (M)
proteins. The fourth genus of influenza, named influenza D, has been recently described
(https://www.cdc.gov/flu/about/viruses/types.htm). Influenza D (IDV) represents a novel
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type of virus, which is more closely related to influenza C (ICV) than influenza A (IAV)
or influenza B (IBV) (B. M. Hause et al., 2013). IDV is unique among four influenza
types in that it utilizes bovine as a primary reservoir and amplification host with
periodically spillover to other mammalian hosts (M. F. Ducatez et al., 2015; L. Ferguson
et al., 2015; E. Foni et al., 2017; B. M. Hause et al., 2014; B. M. Hause et al., 2013; M.
Quast et al., 2015; E. Salem et al., 2017; S. K. White et al., 2016; S. L. Zhai et al., 2017).
Since its first isolation from a pig with influenza-like symptoms in Oklahoma of the
United States in 2011, IDVs have been found in cattle and swine populations in North
America and Eurasia (M. F. Ducatez et al., 2015; L. Ferguson et al., 2015; E. Foni et al.,
2017; B. M. Hause et al., 2014; B. M. Hause et al., 2013; W. M. Jiang et al., 2014; M.
Quast et al., 2015; E. Salem et al., 2017; S. K. White et al., 2016; S. L. Zhai et al., 2017).
Susceptibility to infection by this novel virus has also been demonstrated in sheep, goats,
horses, camelids, guinea pigs, and ferrets (M. F. Ducatez et al., 2015; L. Ferguson et al.,
2015; E. Foni et al., 2017; B. M. Hause et al., 2014; B. M. Hause et al., 2013; W. M.
Jiang et al., 2014; M. Quast et al., 2015; E. Salem et al., 2017; C. Sreenivasan et al., 2015;
S. K. White et al., 2016; S. L. Zhai et al., 2017). Of public health importance, serological
evidence of IDV infections in humans has been demonstrated (B. M. Hause et al., 2013;
S. K. White et al., 2016), and increased IDV outbreaks in pigs have been recently
observed in China and Italy respectively (E. Foni et al., 2017; S. L. Zhai et al., 2017).

To date, IDVs have evolved into two genetic and antigenic lineages, namely
D/OK and D/660, represented by well-characterized swine IDV (sIDV) D/OK
(D/swine/Oklahoma/1334/2011)

and

bovine

IDV

(bIDV)

D/660

93
(D/bovine/Oklahoma/660/2013) isolates (E. A. Collin et al., 2015). The recognition of
terminal Sialic acids (SAs) of sialoglycans exposed on the cell surface is a first and
critical step of the influenza virus lifecycle. Using a fluorescent dye labeled recombinant
Hemagglutinin-Esterase-Fusion (HEF) protein of sIDV D/OK, a recent study found that
sIDV HEF protein interacted with both α2,3 and α2,6-linked 9-O-acetylated SAs (H.
Song et al., 2016), suggesting that sIDV likely utilizes them as its receptors for virus
entry. Furthermore, this study resolved the sIDV HEF crystal structure, and showed that
sIDV differed from its related ICV in that its HEF protein possessed an open receptorbinding cavity (H. Song et al., 2016), which may allow IDV to accommodate more
diverse glycan moieties containing a 9-O-acetly group and as a result increase its tissue
and species tropisms. ICV utilizes 9-O-acetylated N-acetylneuraminic acid (Neu5,9Ac2)
with either α2,3 or α2,6 linkage as a functional receptor (P. B. Rosenthal et al., 1998).
ICV has been thought to have a narrow tissue tropism and a limited host range (Y.
Matsuzaki et al., 2016).

Despite the progress, little is known about the functional relevance of identified 9O-acetylated Neu5Ac (Neu5,9Ac2) and Neu5Gc (Neu5Gc9Ac) (H. Song et al., 2016),
putative candidate receptors of IDV, in the context of viral infection. Receptor biology of
the bovine D/660 lineage has remained uncharacterized. As such, further investigation
into the receptor biology of IDV and biological relevance of various SA forms carrying a
9-O-acetyl group in IDV infection is needed because it will offer novel insights into how
influenza viruses such as IDV originating from a novel bovine reservoir frequently spill
over and transmit to new hosts including pigs and humans.
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3.2 Materials and methods
3.2.1 Viruses and cells
Madin-Darby Canine Kidney (MDCK) cells (ATCC) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) at 37 °C
with 5 % CO2. IAV (H1N1 A/WSN/1933 virus), IBV (B/Brisbane/60/2008), ICV
(C/Johannesburg/1/66),

IDVs

(D/swine/Oklahoma/1334/2011

and

D/bovine/Oklahoma/660/2013), used for the Hemagglutiniation or the cell-based
inhibition assay, were propagated in MDCK cells with DMEM containing 1ug/ml Tosyl
phenylalanyl

chloromethyl

ketone

(TPCK)-trypsin

(Sigma-Aldrich).

ICV

(C/Johannesburg/1/66) and bIDV (D/bovine/Oklahoma/660/2013) used for the glycan
array were propagated in 9 day-old embryonated specific-pathogen-free (SPF) chicken
eggs.

3.2.2 Sialic acids removal assay
1 ml 5% Turkey red blood cells (RBCs) (Lampire) were treated with 200 milliunits (mU)
Neuraminidase from Clostridium perfringens (Sigma-Aldrich) at 37 °C for 1 hour (h).
After 1 h treatment, RBCs were washed with PBS for 3 times and then diluted to a final 1%
concentration in PBS for the hemagglutination (HA) assay. 25 µl of each virus with four
HA units were mixed with same amount of Neuraminidase-treated RBCs, followed by 1
h incubation at 4 °C before observing results. Non-treated RBCs were used as control.

3.2.3 Hemagglutination (HA) assay-based competitive inhibition assay
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Bovine submaxillary mucin (BSM) (Sigma-Aldrich), synthetic 5-N-acetyl-9-O-acetyl
neuraminic acid (Neu5,9Ac2) and 5-N-acetyl-4-O-acetyl neuraminic acid (Neu4,5Ac2)
(Applied Biotech, Austria) were added to different types of viruses containing four HA
units each. Mixtures were incubated for 30 min at room temperature. 25 µl of Turkey
RBCs were added to the mixtures followed by reading results after 30 min incubation at
room temperature.

3.2.4 9-O acetylated group removal assay
20 ug pure, synthetic Neu5,9Ac2 (Applied Biotech) were treated with 5 mU sialate-9-Oacetylesterase (9-O-SE) (Applied Biotech) at 37 °C for 3 h. Four HA units of different
types of viruses were incubated with 9-O-SE treated or non-treated Neu5,9Ac2 for 30 min
at room temperature. Then 25ul of Turkey RBCs were added and results were observed
after 30 min incubation at room temperature. All HA assays were performed in three
independent assays with each in triplicate.

3.2.5 Cell-based inhibition assay by receptor analogs (Digital Droplet PCR)
25 µl IDV and ICV containing 100 TCID50 were respectively pretreated with an equal
volume of Neu5,9Ac2, Neu5Gc9Ac and Neu5Ac receptor analogs at 20, 80 and 320
ng/µl concentrations for 30 min at 4 °C. MDCK cells in 96-well plates were washed once
with PBS and then infected with virus-receptor analogue mixtures for 1h. Cells were
washed three times and further incubated in DMEM containing 1 µg/ml TPCK-trypsin
for 6 h. After 6 h post infection (hpi), supernatants were removed and cells in each well
were lysed with 200 µl Trizol (Life Technologies). Total RNAs were extracted according
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to manufacturer’s instructions, which were then followed by reverse transcription
reactions with oligo(dT) primer and High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). NP segment-derived mRNA molecules of ICV and IDV were
selected as our target for determining the effects of various receptor analogs on viral
replication, while the mRNA of TATA-Box binding protein (TBP) of canine was used as
the reference gene for PCR data normalization. The detailed information for primers and
probes is provided in Table 3.5. The ddPCR reaction consisted of 10 µl 2x Supermix for
Probes (Bio-Rad), 900 nM primers, 25 nM probes and 8 µl undiluted cDNA into a final
volume of 20 µl. All samples were tested in three independent experiments with each
assayed in triplicate. Non- template controls (NTC) were included in every run. Viral
mRNA copies were normalized with TBP references and results were reported as NP
mRNA copies per million TBP.
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Table 3.5. Primers and probes used for digital droplet PCR.

Target genes

IDV NP

ICV NP

Canine TBP

Primers/probes name Primers/probes sequence
qD660NP-For

5’-TGCCGATTGGTGGAGTCAA-3’

qD660NP-Rev

5’-TTTCAGTGCCATTCCCAATCT-3’

qD660NP-Probe

5'-6FAM-AGCTGGGAAATGTAGTGC-MGBNFQ-3’

qJHBNP-For

5’-TGAAGCCTACATTGCCATTTGT-3’

qJHBNP-Rev

5’-GCCATTTTCCAGGATCAACATT-3’

qJHBNP-Probe

5'-6FAM-AGGAAGTGGGCCTTAA-MGBNFQ-3’

Canine-TBP-For

5’-AGGATGATCAAACCCAGAATTGTT-3’

Canine-TBP-Rev

5’-GCCCTTTAGAATAGGGTAGATGTTTTC-3’

Canine-TBP-Probe

5’-VIC-TTGTACTAACAGGTGCTAAAG-MGBNFQ-3’

3.2.6 Virus labeling and sialylated glycan microarray (SGM)
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IDV and ICV were propagated in 9 day-old embryonated SPF chicken eggs. Allantonic
fluid were harvest at 3 dpi followed by a brief centrifugation at 2,000 x g for 20 min at
4°C. The clarified supernatant was layered over a 20% sucrose cushion in PBS buffer and
then ultracentrifuged at 100,000 x g for 2h at 4 °C in a SW28 rotor (Beckman Coulter).
Pellets were resuspended in PBS and further purified over a 30–60% cold sucrose
gradient at 28,000 rpm for 4h at 4 °C in an SW 28 rotor. Fractions (1.0 ml) were collected
from the top and all fractions showing greater or equal to 6 log 2 HA units were pooled
together, followed by a final ultracentrifugation through a 20 % sucrose cushion (w/v) in
PBS at 100, 000 g for 2h at 4 °C. The pellets were resuspended in CMS buffer (0.15M
NaCl, 0.25mM CaCl2, 0.8 mM MgCl2, PH 7.4) and diluted to a solution containing 1.0 x
105 HAU (HA unit)/ml.

We employed the standard protocol to generate dye-labeled IDV and ICV virions as
described previously (X. Song et al., 2011). In brief, 10 µl of 1.0 M sodium bicarbonate
(pH 9.0) was added into 100 µl purified viruses containing ~1.0 × 104 HA units) followed
by addition of Alexa Fluor-488 succinimidyl ester (Molecular Probes) in a ratio of 0.005
µg Alexa per HAU. This ration was determined by the HA titration experiment to give
maximal labeling without loss of binding activity. After stirring for 1 h at room
temperature in the dark, the labeling reaction mixtures were dialyzed (Slide-A-Lyzer
Mini Dialysis Units 7000 MWCO, Pierce) in CaMgS (0.25 mM CaCl2, 0.8 mM MgCl2 in
borate buffered saline, pH 7.2) at 4°C overnight. After functional evaluation (HA
activity), labeled viruses were ready for glycan receptor binding experiment.
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To determine the glycan-binding specificities of labeled IDV and ICV, a glycan screen
array was performed at the Consortium for Functional Glycomics. The printed glycan
array consists of 77 sialylated glycans incorporating 16 modified sialic acids in α2–3 and
α2–6 linkages to different underlying structures (X. Song et al., 2011). Briefly,
fluorescently labeled virus was incubated on a glycan microarray slide under a coverslip
at 4°C for 1 h, washed to remove unbound virus, and scanned using a ProScan Array
(Perkin-Elmer Life sciences) equipped with multiple lasers. The data were processed
using the manufacturer's software as described previously, which provided raw values in
relative fluorescence units (RFU) from each spot in an Excel spreadsheet. The intensity
of binding to each of the 77 glycans on the array was graphed and shown as values
representing means ± S.D.s of six replicate samples.

3.3 Results
3.3.1 9-O-acetylation group is a critical sialic acid receptor determinant of IDV.
We first employed the traditional hemagglutination (HA) assay-based competitive
inhibition approach to determine the glycan receptor of IDV. To determine whether sialic
acids serve as a component of the receptor for IDV, we treated Turkey RBCs with
neuraminidase from Clostridium perfringens. As summarized in Table 3.1, pretreatment
with neuraminidase resulted in a complete loss of RBC agglutination mediated by IDV as
well as by IAV A/WSN/1933 (H1N1) or IBV (B/Brisbane/60/2008) or ICV
(C/Johannesburg/1/66) (4 HA units used for each virus per reaction). This result indicated
that sialic acids are involved in IDV-mediated RBC agglutination.
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Table 3.1. The effects of Neuraminidase (NA) treatment on viral ability in
agglutination of Turkey red blood cells.

Virus

Untreated RBCs

NA-treated RBCs

IAV A/WSN/1933 (H1N1)

-a

+b

IBV B/Brisbane/60/2008

-

+

ICV C/Johannesburg/1/66

-

+

IDV D/bovine/Oklahoma/660/2013

-

+

a indicates evident hemagglutination (no inhibitory effect) in the wells.
b denotes non-hemagglutination (inhibitory effect) in the wells.

Agglutination of RBCs by IDV was also inhibited in the presence of a range of
concentration of bovine submaxillary mucin (BSM) (from 6.25 to 400 ng), which is rich
in 9-O-acetylayed Neu5Ac (Neu5,9Ac2) and Neu5Gc (Neu5Gc9Ac) (Table 3.2) (M. A.
Langereis et al., 2015). Intriguingly, the level and pattern of inhibition of IDV-mediated
RBC agglutination by BSM were similar to that observed in ICV that is known to utilize
Neu5,9Ac2-containing glycan as a receptor for viral entry (P. B. Rosenthal et al., 1998),
thereby suggesting that IDV likely utilizes Neu5,9Ac2 molecule as a receptor for
attachment.
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Table 3.2. The effects of bovine submaxillary mucin (BSM) treatment on viral
ability in agglutination of Turkey red blood cells.

Virus

BSM (ng)
PBS

6.25

25

100

400

IAV

-b

-

-

-

-

IBV

-

-

-

-

-

ICV

-

-

+c

+

+

IDV

-

-

+

+

+

DMEM

-

-

-

-

-

a viruses used in this experiment were IAV IAV A/WSN/1933 (H1N1), IBV
(B/Brisbane/60/2008),

ICV

(C/Johannesburg/1/66),

and

(D/bovine/Oklahoma/660/2013) (4 HA units used for each virus per reaction).
b indicates evident hemagglutination (no inhibitory effect) in the wells.
c denotes non-hemagglutination (inhibitory effect) in the wells.

IDV
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To further confirm these results, we performed the HA assay involving a synthetic
Neu5,9Ac2. For a control, Neu4,5Ac2 was used, which has O-acetyl group in the C4, not
C9 position. RBC agglutination by IDV and ICV was not inhibited by Neu4,5Ac2 (up to
102 µg/per well, the maximum concentration used). In contrast, agglutination started to
be completely lost for IDV at the presence of 1.6 µg Neu5,9Ac2 per well and for ICV at
6.4 µg Neu5,9Ac2 per well (Table 3.3). This result further demonstrated that Neu5,9Ac2
is a sialic acid receptor of IDV. It is interesting to note that the minimal concentration to
abolish ICV-mediated RBC agglutination was 4 times higher than that needed for IDV.

Table 3.3. The effects of synthetic Neu5,9Ac2 and Neu4.5Ac2 receptor analogs on
viral ability in agglutination of Turkey red blood cells.

Virusa

Neu5,9Ac2 (ng/ul)
PBS

5

20

80

320

1280

IAV

-b

-

-

-

-

-

IBV

-

-

-

-

-

-

ICV

-

-

-

+c

+

+

IDV

-

-

+

+

+

+

DMEM

-

-

-

-

-

-
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Virusa

Neu4,5Ac2 (ng/ul)
PBS

5

20

80

320

1280

IAV

-b

-

-

-

-

-

IBV

-

-

-

-

-

-

ICV

-

-

-

-

-

-

IDV

-

-

-

-

-

-

DMEM

-

-

-

-

-

-

a

viruses used in this experiment were IAV IAV A/WSN/1933 (H1N1), IBV

(B/Brisbane/60/2008),

ICV

(C/Johannesburg/1/66),

and

IDV

(D/bovine/Oklahoma/660/2013) (4 HA units used for each virus per reaction).
b

indicates evident hemagglutination (no inhibitory effect) in the wells.

c

denotes non-hemagglutination (inhibitory effect) in the wells.

Finally, pretreatment of the synthetic Neu5,9Ac2 with recombinant sialate-9-Oacetylesterase (9-O-SE) (e.g., removes 9-O-acetylated group) abolished its inhibitory
effect of IDV- or ICV- mediated RBC agglutination, whereas binding and agglutination
of RBCs by IAV were not affected (Table 3.4). In summary, the results of our qualitative
HA-based experiments suggest that IDV uses Neu5,9Ac2 as a receptor for infection.
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Table 3.4. The effects of synthetic Neu5,9Ac2 receptor analog and recombinant
sialate-9-O-acetylesterase (9-O-SE) pretreated Neu5,9Ac2 on viral ability in
agglutination of Turkey red blood cells.

Virus

PBS

Neu5,9Ac2

Neu5,9Ac2 with

9-O-SE

9-O-SE

with PBS

IAV

-b

-

-

-

ICV

-

+c

-

-

IDV

-

+

-

-

a viruses used in this experiment were IAV IAV A/WSN/1933 (H1N1), ICV
(C/Johannesburg/1/66), and IDV (D/bovine/Oklahoma/660/2013) (4 HA units used for
each virus per reaction).
b indicates evident hemagglutination (no inhibitory effect) in the wells. c denotes nonhemagglutination (inhibitory effect) in the wells.

3.3.2 Receptor binding characteristics of labeled IDV and ICV on a sialylated glycan
microarray (SGM).
In parallel, we utilized sialylated glycan microarray technology to examine the specific
glycans that serve as potential receptors for IDV and ICV. The SGM provided by the
Consortium for Functional Glycomics consists of 77 sialylated glycans incorporating 16
modified sialic acids in α2,3 and α2,6 linkages to different underlying structures (X. Song
et al., 2011). Under an identical condition, we found that IDV preferred to bind glycans
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terminated in either Neu5,9Ac2 (IDs#38 and 52) or Neu5Gc9Ac (IDs#39 and 53) (Fig.
3.1A). Other forms of glycans failed to achieve significant interactions with IDV,
indicating a specific binding directed largely by the 9-O-acetyl group. Binding of IDV to
9-O-acetylated glycans was not dependent on the specific linkage (α2,3 or α2,6) (IDs#39
Vs. 53 and 38 Vs. 52) (Fig. 3.1C). ICV array did not give clear data (low signal/noise
ratio). Nevertheless, only #38 glycan terminated with Neu5,9Ac2 (α2,6 linkage) showed
consistent interactions with ICV (Fig. 3.1B) in our repeated SGM experiments.
Neu5,9Ac2 has been shown previously as a receptor determinant of ICV infection (G. N.
Rogers et al., 1986). In summary, the glycan array-based data are consistent with the
observations of the HA-based experiments, thereby further demonstrating that IDV
utilize 9-O-acetylated SAs-containing glycans as receptors for viral entry and infection.
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Figure 3.1. Identification of 9-O-acetylated sialic acid receptors of influenza D virus.
Glycan binding analyses as measured by relative fluorescence intensity (RFU) are
presented for labeled IDV (A) and ICV (B) respectively. The structures of the sialylated
glycans showing a significant interaction with IDV are listed in (C) with a “*” sign
indicating a glycan that binds to both IDV and ICV. In brief, Alexa488 fluorescencelabeled purified IDV or ICV was incubated at 4°C for 1 h on the printed glycan array that
consists of 77 sialylated glycans incorporating 16 modified sialic acids in α2,3 and α2,6
linkages to different underlying structures. Following washing six times to remove
unbound viruses, the slides were scanned using a ProScan Array (Perkin-Elmer Life
sciences) equipped with four lasers covering an excitation range from 488 to 637 nm. For
Alexa488 fluorescence, 495 nm (excitation) and 510 nm (emission) were used. The data
were processed using the manufacturer's software, which provided raw values in relative
fluorescence units (RFU) from each spot in an Excel spreadsheet. The intensity of

108
binding to each of the 77 glycans on the array was graphed and shown as values
representing means ± S.D.s of the four replicates. Note that an equal amount of purified
IDV or ICV (500 HA units) was used for the glycan array analysis. The data presented in
this figure are representative of two independent glycan microarray experiments
performed in the four replicates.

3.3.3 Functional studies of the roles of Neu5,9Ac2- or Neu5Gc9Ac-containing glycans
in IDV and ICV infection. To determine the functional relevance of these receptor
candidates, we first tested four synthetic glycans and examined their ability to disrupt the
agglutination of Turkey RBCs by IDV and ICV in hemagglutination inhibition format
where we replaced antibody with receptor analog with four hemagglutination (HA) unitworking concentration used for each virus per reaction. These four glycans are Neu5Acα2-3LNnT-beta-Propyl

N3,

Neu5Gc-α2-3LNnT-beta-Propyl

N3,

Neu5Ac9Ac-α2-

3LNnT-beta-Propyl N3, and Neu5Gc9Ac-α2-3LNnT-beta-Propyl N3. As shown in Fig.
3.2A, the presence of both Neu5,9Ac2 and Neu5Gc9Ac at a concentration of 20 ng/ul and
above resulted in a complete loss of RBC agglutination by IDV. In contrast, neither
Neu5Ac nor Neu5Gc affected IDV-mediated RBC agglutination, thereby confirming our
glycan array data. Interestingly, we noticed that ICV needed 4 and 16 times higher
concentrations of Neu5,9Ac2 and Neu5Gc9Ac, respectively, than IDV for completely
losing RBC agglutination. This result suggests that IDV binds both 9-O-acetylated SAs
with an affinity higher than ICV, and ICV prefers Neu5,9Ac2 over Neu5Gc9Ac.
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In parallel, four synthetic glycans were examined for their ability to inhibit the replication
of ICV (Fig. 3.2B) and IDV (Fig. 3.2C) in a MDCK cell-based multiple round replication
assay format. After pretreatment for 30 min at 4 ºC, MDCK cells were infected with 100
TCID50 of IDV or ICV, followed by additional 6h incubation. Extracted cellular RNAs
were subjected to reverse transcription with oligo (dT) followed by Bio-Rad QX200
Droplet Digital ddPCR (targeting NP mRNA). Copy numbers of NP-specific mRNA in
each reaction were normalized to internal reference gene encoding TATA box binding
protein (TBP) to derive relative copy number of viral NP mRNA. The detailed
information for primers and probes is provided in Table 3.5. As shown in Fig. 3.2C, both
Neu5,9Ac2 and Neu5Gc9Ac exhibited a dose-dependent inhibition of IDV replication.
For example, IDV infectivity was reduced approximately by 50% with Neu5,9Ac2 and by
40% with Neu5Gc9Ac at 64 ng/µl, respectively, whereas the infectivity was reduced by
90% with either treatment at 1024 ng/µl. Similarly, a dose-dependent inhibition of ICV
was observed by the above receptor analogs but the inhibition levels were less
pronounced (Fig. 3.2B). ICV replication was inhibited significantly more by Neu5,9Ac2
than Neu5Gc9Ac (Fig. 3.2B). The results from cell-based and HA-based inhibition assays
were in good agreement with each other, thereby further validating our findings from
glycan array experiments. In summary, our data suggest that IDV binds both Neu5,9Ac2
and Neu5Gc9Ac equally well, while ICV prefers Neu5,9Ac2 over Neu5Gc9AC. Our
results also indicate that IDV is more efficient in recognizing Neu5,9Ac2 and
Neu5Gc9Ac receptors than ICV.
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Figure 3.2. Inhibition of viral hemagglutination and infection by receptor analogs.
(A) A loss of Turkey RBC agglutination by ICV or IDV at the presence of synthetic
receptor analog. Indicated receptor analogs at various concentrations (1.25, 5, 20, 80, 320
ng/ul) were added to IDV or ICV containing four HA units each. Mixtures were
incubated for 30 min at room temperature. 25 µl of Turkey RBCs were then added to the
mixtures followed by reading results after 30 min incubation at room temperature.
Normal medium DMEM was used as a negative control. Note that “+” sign indicates no
hemagglutination, while “-” denotes evident hemagglutination. The data presented in
panel A are representative of four independent experiments performed in duplicate.
Inhibition of ICV (B) and IDV (C) replication in an MDCK-based replication assay by
receptor analogs as determined by Digital Droplet PCR. 25 µl IDV and ICV containing
100 TCID50 were respectively pretreated with an equal volume of Neu5,9AC2 or
Neu5Gc9Ac or Neu5Ac receptor analogs at 20, 80 and 320 ng/µl concentrations for 30
min at 4 °C. MDCK cells in 96-well plates were washed once with PBS and then infected
with virus-receptor mixtures for 1h. Cells were washed three times and further incubated
in DMEM containing 1 µg/ml TPCK-trypsin for 6 h. After 6 h post infection (hpi),
supernatants were removed and cells in each well were lysed with 200 µl Trizol. Total
RNAs were extracted according to manufacturer’s instructions, which were then followed
by reverse transcription reactions with oligo(dT) primer and High-Capacity cDNA
Reverse Transcription Kit. NP segment-derived mRNA molecules of ICV and IDV were
selected as our target for determining the effects of various receptor analogs on viral
replication, while the mRNA of TATA-Box binding protein (TBP) of canine was used as
the reference gene for PCR data normalization. The detailed information for primers and
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probes is provided in Table 3.5. The ddPCR reaction consisted of 10 µl 2x Supermix for
Probes (Bio-Rad), 900 nM primers, 25 nM probes and 8 µl undiluted cDNA into a final
volume of 20 µl. Non- template controls (NTC) were included in every run. Viral mRNA
copies were normalized with TBP references and results were reported as NP mRNA
copies per million TBP. Receptor analog-mediated inhibitory effects were shown for ICV
in panel B and for IDV in panel C as values representing means ± S.D.s of three
independent experiments performed in triplicate.

3.4 Discussion
Neu5Gc and Neu5Gc9Ac are generally abundant in many agricultural animals
such as cattle and swine (A. N. Samraj et al., 2015), but are absent in humans and ferrets
due to frame-shift mutations of CMAH that converts Neu5Ac to Neu5Gc (A. Irie et al.,
1998; P. S. Ng et al., 2014), the substrate of the Neu5Gc9Ac. The efficient usage of either
Neu5,9Ac2 or Neu5Gc9Ac as a receptor likely gives IDV an ecological niche to infect
multiple agricultural animals with abundant expression of Neu5Gc9Ac as well as humans
only expressing Neu5,9Ac2. The zoonotic risk to humans by IDV is further supported by
our previous study showing that humans-like ferrets are susceptible to IDV infection (C.
Sreenivasan et al., 2015). It should be noted that despite the genetic inability to
synthesize Neu5Gc and its derivative Neu5Gc9Ac, humans still possess the cellular 9-Oacetylation machinery for the synthesis of 9-O-acetylated sialic acids. In this regard,
humans can take Neu5Gc from dietary sources, convert it into Neu5Gc9Ac, and express
it on the cell surfaces of various cell types (M. Bardor et al., 2005). It has been shown
previously that Neu5Gc and possible its 9-O-acetylated form (Neu5Gc9Ac) can
accumulate in human cancer cells with an unknown mechanism (S. Inoue et al., 2010). In
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light of the fact that exogenous expression non-human Neu5Gc can make humans
vulnerable to pathogens utilizing Neu5GC as a receptor for infection (E. Byres et al.,
2008), it will be interesting to address in the near future whether humans or ferrets
expressing exogenous Neu5Gc9Ac under certain conditions are more susceptible to IDV
infection.

Humans are thought to be the primary host and reservoir of ICV, although this
virus has been identified in other hosts probably after reverse zoonotic transmission from
humans (Y. Matsuzaki et al., 2016). Our observation that ICV preferentially uses
Neu5,9Ac2 over Neu5Gc9Ac appears to support this theory. First, as discussed above, the
evolutionary loss of CMAH gene for conversion of Neu5Ac to Neu5Gc may make
humans exclusively and abundantly express Neu5Ac and Neu5,9Ac2 (A. Irie et al., 1998).
As such humans become a perfect host for ICV that selectively prefers Neu5,9Ac2 for
viral attachment and infection. Second, agricultural animals such as cattle and pigs that
are rich in Neu5Gc can express high levels of Neu5Gc9Ac (A. N. Samraj et al., 2015).
Because a significant portion of Neu5Ac has been converted to Neu5Gc in these animals,
the number of Neu5Ac molecule available for Neu5,9Ac2 synthesis are substantially
reduced. Reduced expression of the Neu5,9Ac2 receptor may render agricultural animals
become less susceptible to ICV infection when compared to humans. In case that these
animals would be infected by ICV after reverse zoonotic transmission from humans, it is
questionable that ICV transmission can be sustained among them. On the other hand,
IDV differs from ICV in that it effectively engages with no clear preference both
Neu5,9Ac2 and Neu5Gc9Ac receptors. One can envision that the differential expression
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levels of these two 9-O-acetylayed sialic acids in animals and humans may not
substantially affect IDV replication and spread. And therefore, this unique receptor
binding property should enable IDV effectively infect and transmit among different
mammalian hosts including humans.

9-O-acetylated derivatives (Neu5,9Ac2 and Neu5Gc9Ac) and their precursors
(Neu5Ac and Neu5Gc) are most common sialic acids in nature (X. Song et al., 2011).
Neu5Gc9Ac is different from Neu5,9Ac2 only by an additional oxygen atom at the C5
position (X. Song et al., 2011). The differential usage of these two nearly identical 9-Oacetylated SAs between IDV and ICV implies that two seven-segmented influenza
viruses diverge in communicating with both O-acetyl group at the C9 position and
acetyl/glycolyl groups at the C5 position in terminal 9-carbon sialic acids. We interpret
our experimental data presented here that IDV in general may have high binding affinity
and broad specificity, while ICV may have lower binding affinity and narrow selectivity
for 9-O-acetylated SAs. Such qualitative and quantitative differences in the virus-glycan
receptor interaction that may ultimately discriminate IDV from its related ICV in
infectious landscape and ecology, which clearly warrant further investigation.
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Chapter 4. Genesis, antigenic evolution, and temperature-dependent replication of a
recent human influenza C virus clinical isolate

Abstract: Unlike influenza A and B viruses that infect humans and cause severe diseases
in seasonal epidemics, influenza C virus (ICV) is a ubiquitous childhood pathogen
typically causing mild respiratory symptoms. ICV infections are rarely diagnosed and
less research has been performed on it despite the virus being capable of causing severe
disease in infants. Here we report on the isolation of a human ICV from a child with
acute respiratory disease, provisionally designated C/Victoria/2/2012 (C/Vic). The fulllength genome sequence and phylogenetic analysis revealed that the hemagglutininesterase-fusion (HEF) gene of C/Vic was derived from C/Sao Paulo lineage, PB2, PB1,
M and NS of C/Vic were classified into C/Yamagata-related lineage, while P3 and NP
were divided into C/Mississippi-related lineage. Furthermore, antigenic analysis using the
HI assay found that 1947 C/Taylor virus (C/Taylor lineage) was antigenically more
divergent from1966 C/Johannesburg (C/Aichi lineage) than from 2012 C/Vic. Structure
modeling of the HEF protein identified two mutations in the 170-loop of the HEF protein
around the receptor binding pocket as a possible antigenic determinant responsible for the
discrepant HI results. Finally, C/Vic was found to replicate more efficiently at the cool
temperature found in the nasal cavity (33 °C) than at the core body temperature (37 °C)
in a panel of epithelial cell lines from human, swine and canine. Taken together, results
of our studies reveal novel insights into the genetic and antigenic evolution of ICV and
provide a framework for further investigation of the molecular determinants of
temperature-dependent growth and antigenic property.
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4.1 Introduction

The Orthomyxoviridae family has four genera of influenza viruses, influenza A, influenza
B, influenza C, and influenza D. Among them, influenza A, B, and C are known to cause
moderate to severe respiratory diseases in humans. Specifically, human infections by
influenza A (IAV) and B (IBV) viruses can lead to severe respiratory diseases, while
influenza C virus (ICV) usually causes mild upper respiratory diseases in humans,
although it has the ability in causing severe lower respiratory illness in children less than
2 years of age (S. Katagiri et al., 1983; Y. Matsuzaki et al., 2006; H. Moriuchi et al.,
1991). ICV is distributed worldwide (A. C. Dykes et al., 1980; Y. Matsuzaki et al., 2016;
H. Nishimura et al., 1987) and multiple genetic lineages co-circulate globally (D. A.
Buonagurio et al., 1986; Y. Furuse et al., 2016; Y. Matsuzaki et al., 2000; Y. Matsuzaki
et al., 1994). In addition to three genera of influenza viruses that all infect humans, a new
group of influenza viruses with cattle as a primary reservoir has been recently described
and these new viruses are classified into influenza D genus due to its distinctness from
other influenza genera (E. A. Collin et al., 2015; B. M. Hause et al., 2014; B. M. Hause et
al., 2013; Z. Sheng et al., 2014). Influenza D viruses (IDV) are thought to primarily infect
and cause respiratory diseases in cattle and to some extent in pigs. Nevertheless, IDVspecific antibodies had been found in humans, especially those who had a previous
history of contact with cattle.
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Among human influenza viruses, ICV infections are rarely diagnosed and less research
has been performed on it despite the virus having the ability to cause severe diseases in
newborn infants. Previous analyses of the hemagglutinin-esterase-fusion (HEF) gene,
encoding the antigenic determinants of viruses, have divided ICVs into six genetic and
antigenic

lineages,

designated

C/Taylor,

C/Mississippi,

C/Aichi,

C/Yamagata,

C/Kanagawa, and C/Sao Paulo (S. Hachinohe et al., 1989; Y. Matsuzaki et al., 2003; Y.
Matsuzaki et al., 1994; Y. Muraki et al., 1996; K. Sugawara et al., 1988; K. Sugawara et
al., 1993). ICV is thought to evolve relatively slow compared to IAV or IBV to a lesser
extent (P. Chakraverty, 1974; Y. Furuse et al., 2016; H. Kawamura et al., 1986; Y.
Muraki et al., 1996). However, frequent reassortments among ICVs have always occurred
in nature and most of the circulating ICV are generated due to various reassortantments
involving multiple ICV lineages (Y. Matsuzaki et al., 2003). Co-circulation of several
ICV lineages in humans has been well documented (Y. Matsuzaki et al., 1994). Genetic
diversity and the associated antigenic drift caused by reassortment play an important role
in driving ICV’s periodical recurrence in humans. To date, the majority of published
research on human ICV utilized historic reference virus strains isolated between the
1950s and 1960s. As such, more studies of currently circulating strains of ICV are
critically needed in order to better understand the epidemiology, genetic and antigenic
evolution, and biology of this group of human influenza viruses, which can pose a
significant risk to worldwide infant population.

Here we described the isolation of a contemporary influenza C virus - C/Victoria/2/2012
(C/Vic) - from a diseased child with acute respiratory symptoms in 2012. Phylogenetic
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analysis indicated that viral HEF gene was derived from C/Sao Paulo lineage, which is
consistent with the finding that the dominant antigenic group is C/Sao Paulo lineage from
2006 to 2016 (Y. Matsuzaki et al., 2014; T. Odagiri et al., 2015; S. Tanaka et al., 2015; T.
Yano et al., 2014). PB2, PB1, M and NS of C/Vic were classified into C/Yamagatarelated lineage, while P3 and NP were divided into C/Mississippi-related lineage.
Furthermore, antigenic analysis using the HI assay found 1947 C/Taylor virus (C/Taylor
lineage) was antigenically more divergent from1966 C/Johannesburg (C/Aichi lineage)
than from C/Vic. Structure modeling of the HEF protein identified two mutations in the
170-loop of the HEF protein around the receptor binding pocket as a possible antigenic
determinant responsible for the discrepant HI results. Growth kinetics studies conducted
at both cool (33 °C) and core body (37 °C) temperature demonstrated a temperaturedependent replication property for this contemporary ICV isolate. Information obtained
through this study shall provide novel insights into genesis, antigenic evolution and
replication biology of human influenza C virus.

4.2 Materials and Methods
4.2.1 Cell and virus cultures
Madin-Darby canine kidney (MDCK), human lung adenocarcinoma A549 (A549),
human lung adenocarcinoma Calu-3 (Calu-3), Swine Testicle (ST), Swine tracheal and
bronchial epithelial cell line-MK1-OSU (MK1-OSU) and SD-PJEC cells, a subclone of
the IPEC-J2 cell line, originally derived from newborn piglet jejunum, were grown in
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) at
37 °C with 5% CO2. The infectious culture medium is serum-free DMEM containing a
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final concentration of 0.0005% trypsin (Sigma-Aldrich, St Louis, USA). Virus cultures
were incubated at 33 °C for up to 7 days or development of cytopathic effect (CPE).

4.2.2 Genome sequencing and phylogenetic analysis
Viral RNA was isolated using a MagMAX™ Viral RNA Isolation kit. Full genome
amplification was performed as previously described except that the primers were
modified

to

match

the

non-coding

ACGCGTGATCGCATAAGCAG-3’

regions
and

of

ICV:

“ICV3’”,

“ICV5’”,

5’5’-

ACGCGTGATCAGCAGTAGCAAG-3’. Amplicons were used for library preparation
using the NEBNext® Fast DNA Library Prep Set for Ion Torrent™. Libraries were
sequenced using an Ion Torrent Personal Genome Machine with manufacturer’s reagents
and protocols. Contigs were assembled with C/Ann Arbor/1/50 (accession numbers
NC_006306-NC_006312) as templates, which were analyzed by the SeqMan NGen
module from DNAStar. Nucleotide sequences were edited and compiled using the
Lasergene 8 software package (DNASTAR, Inc.). The genome sequence of C/Vic was
submitted to GenBank under accession numbers KM504277-KM504283.
The genome sequences of C/Vic were determined in our laboratory. The sequences of
other ICV and IDV strains were obtained from GenBank. To fully understand the
evolutionary history of ICVs, the six strains (C/Taylor, C/Mississippi, C/Aichi,
C/Yamagata, C/Kanagawa, and C/Sao Paulo) represented the six genetic and antigenic
lineages were included in the phylogenetic analysis of each RNA segment. Reference
viruses included historic ICVs such as C/Ann Arbor/1/50 and C/Taylor/1233/1947, as
well as contemporary viruses. Identical sequences were removed and only the ones with
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the earliest isolation time were used. Incomplete sequences were removed. The complete
coding regions of each segment was used to construct phylogenetic trees.

Sequences of each segment were aligned at the amino acid level using Muscle (ref), and
the aligned sequences were translated back to generate alignments of nucleotide
sequences, which were used for phylogenetic tree construction using MEGA6 (ref). The
best substitution model for each segment was estimated using MEGA6. The best models
predicted were T92+G for NS and GTR+G+I for the other six segments. The
phylogenetic trees were generated using Maximum-likelihood method in MEGA6 with
1000 bootstrap replicates to estimate the confidence of the tree topologies. The trees were
rooted using the ancestor branches of IDV strains.

4.2.3 Hemagglutination inhibition assay
Antibody cross-reactivity was determined using a panel of reference viruses and antisera
in hemagglutination inhibition (HI) assays. Chicken antiserum against C/ Taylor/1233/47
(C/Taylor lineage) and C/Taylor/1233/47 virus were provided by NIAID biodefense and
Emerging Infections Research Resources Repository (BEI Resources). Antiserum against
C/Victoria/2/2012

(C/Sao

Paulo

lineage)

was

generated

in

rabbits,

while

C/Johannesburg/1/66 virus (C/Aichi lineage) was provided by Peter Palese at Mt. Sinai
Medical School, New York. All sera were heat inactivated at 56°C for 30 min prior to use.
HI assays were performed following standard procedures. In brief, sera were treated with
a receptor-destroying enzyme for 24 h at 37°C and then adsorbed with a 20% suspension
of turkey erythrocytes in phosphate-buffered saline (PBS) for 30 min at room temperature.
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Virus suspensions containing 4 to 8 HA units of the virus were incubated for 1 h with
serial 2-fold dilutions of antiserum, and the HI titer was determined as the reciprocal of
the highest dilution that showed complete inhibition of hemagglutination using 0.5%
washed turkey erythrocytes (Lampire biological laboratories, Pipersville, PA). All viruses
were assayed in triplicate. Mean HI titers and standard deviations were calculated from
triplicate data. Heterologous mean HI titers were normalized to mean homologous HI
titers (mean heterologous titers/mean homologous titers). Relative HI titers were reported
to account for differences in homologous HI titers between C/Taylor and
C/Victoria/2/2012.

4.2.4 Temperature-dependent virus replication kinetics
MDCK, ST, and MK1-OSU cells were infected with C/Vic at a multiplicity of infection
(MOI) of 0.01 while A549, Calu-3, and SD-PJEC cells were infected with an MOI of 1.0.
The virus was allowed to adsorb to cells incubated at 33 °C or 37 °C for 1 hour (h). The
inoculum was then removed and the cells were washed twice with PBS. Cells were
maintained with DMEM containing tosyl phenylalanyl chloromethyl ketone (TPCK)
treated trypsin (1 µg/ml TPCK-Trypsin for MK1-OSU and MDCK, 0.1 µg/ml TPCKTrypsin for SD-PJEC, A549, Calu-3 and ST). Cells culture supernatants were collected
every 24 hours. Virus titration was performed on MDCK cells. Results were obtained
from two independent experiments.

4.2.5 Structure modeling and sequence alignment

127
The viral HEF sequences (C/Vic and C/Taylor) were modeled with Modeller (N. Eswar
et al., 2007). The structure of C/Johannesburg/1/66 (C/JHB/1/66) was used as template
(sequence identity: 95-96%). Sequences were aligned with Muscle (R. C. Edgar, 2004).
Domain boundaries and the trimeric interface were determined according to those of
C/JHB/1/66 (P. B. Rosenthal et al., 1998). Variant residues of the HEF protein among
three viruses were colored pink.

4.3 Results and Discussion
4.3.1 Virus isolation and full-length genome analysis
In 2012, a nasopharyngeal swab from child patient exhibiting clinical symptoms of acute
respiratory infection was submitted for virus isolation to Victorian Infectious Diseases
Reference Laboratory, Melbourne, Australia. After cultivation in MDCK cells at 33 °C
together with RT-PCR diagnosis and sequence confirmation, human influenza C virus
was isolated from the patient-derived nasopharyngeal swab sample, provisionally
designated C/Victoria/2/2012. The virus cultured in MDCK cells was then sequenced on
an Ion Torrent Personal Genome Machine and De novo genome assembly was employed
to compile viral full-length genome. The full-length sequences of all segments were
determined and used for phylogenetic analysis.

4.3.2 Phylogenetic analysis
To determine the evolutionary pathway of C/Vic, we performed phylogenetic analysis on
all seven segments of C/Vic and reference ICVs. Nucleotide sequences of the complete
coding region for the seven RNA segments were used for phylogenetic tree construction
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(Fig. 4.1). Reference viruses including historic ICVs such as C/Taylor/1947 and C/Ann
Arbor/50, as well as the recent isolates including C/Yamagata/16/2014 and C/EasternIndia/1202/2011 were used in our analysis (T. Roy Mukherjee et al., 2013). We included
all influenza D virus (IDV) strains isolated from 2011 to 2016 to better represent the
evolutionary history of both influenza genotypes. The trees were rooted using the
ancestor branches of IDV strains.

Previous studies of the HEF segment, the primary determinant of host range and target of
virus-neutralizing antibodies, have classified ICVs into six genetic and antigenic lineages,
designated C/Taylor, C/Mississippi, C/Aichi, C/Yamagata, C/Kanagawa, and C/Sao
Paulo. As shown in Fig. 4.1, the HEF-based tree recaptured the currently defined lineage
classification for ICVs, thereby validating our analytical approach. Phylogenetic analysis
of the HEF gene placed C/Vic in C/Sao Paulo lineage, which also includes most recent
ICV isolates from 2006 to 2015. C/Vic is closely clustered together with
C/Yamagata/33/2014 from Japan and two strains C/Biliran/1/2013 and C/Leyte/2/2011
from Philippines. Interestingly several recent ICV isolates, including C/Yamagata/7/2012
and C/Miyagi/2/2014, belonged to C/Kanagawa lineage. This result supports the notion
that multiple ICV lineages have co-circulated in global human populations in recent years.
As shown in Fig. 4.1, in contrast to a HEF-based tree, the topologies of internal branches
of the phylogenetic trees of other segments have low statistical supports, which may be
due to their high sequence similarities. This prevented us from drawing any precise
lineage classification of ICVs. Yoko Matsuzaki et al divided the genetic lineages of the
internal genes into two major lineages, the C/Mississippi-related lineage and the
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C/Yamagata-related lineage (Y. Matsuzaki et al., 2016). From this aspect, PB2, PB1, M
and NS of C/Vic were classified into C/Yamagata-related lineage, while P3 and NP were
divided into C/Mississippi-related lineage. A close examination of the PB2 tree revealed
that C/Vic formed a subgroup with C/pig/Beijing/115/81, a porcine ICV isolated from
pigs with influenza-like symptoms in China in 1981. A similar finding was also observed
in the M gene-derived tree in that C/Vic was closely related to C/pig/Beijing/115/81.
These results indicated the potential that recent ICV strains including C/Vic may replicate
and transmit among pigs. Analysis of PB1 gene-derive tree demonstrated that C/Vic were
closely related to C/Miyagi/5/2014 and C/Tokyo/4/2014. Similar to HEF segment, C/Vic
NS segment was closely clustered together with C/Tokyo/4/2014, C/Biliran/1/2013 and
C/Leyte/2/2011. These results suggested that these viruses were circulating in Australia,
Philippines and Japan from 2011 to 2014. Phylogenetic analysis of the P3 and NP genes
form a subgroup with historical ICV isolates including C/Mississippi/80, C/Nara/82 and
C/Greece/1/79, were classified into C/Mississippi-related lineage. Taken together, the
results of our phylogenetic studies demonstrated that C/Vic is a reassortant virus
composed of segments derived from multiple ICV lineages or strains, which evolved
independently.

The trees were rooted using the ancestor branches of influenza D virus strains. Our
previous study showed IDVs isolated in United States were classified into two distinct
cocirculating lineages represented by D/swine/Oklahoma/1334/2011 (D/OK) and
D/bovine/Oklahoma/660/2013 (D/660) (E. A. Collin et al., 2015). However, the recently
reported D/bovine/Ibaraki/7768/2016 was not clustered into either lineage except M
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segment (S. Murakami et al., 2016). We included all IDV isolates in our phylogenetic
trees to better understand the evolution between ICVs and IDVs. The phylogenetic
analysis showed two distinct lineages of IDVs in PB2 and PB1, M and NS segments. In
P3, HEF and NP gene-derived trees, D/France/2986/2012 and D/Ibaraki/7768/2016 were
not fell into either lineage. Interestingly, several American isolates such as
D/bovine/Minnesota/628/2013, D/bovine/Kansas/13-21/2012 and D/bovine/Texas/313/2011 in P3-derived tree and three isolates from Shandong, China in NP-derived tree
were not clustered into any lineage either. The results demonstrated that more than two
lineages of IDVs are co-circulating all over the world and frequently reassorted with one
another.
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Figure 4.1. Phylogenetic trees of the seven genomic segments of influenza C virus.
Sequences of each segment of human influenza C viruses were aligned and then used for
phylogenetic tree construction through the MEGA7 program. The best substitution model
for each segment was estimated using MEGA7. The phylogenetic trees were generated
using Maximum-likelihood method of MEGA7 with 1000 bootstrap replicates to verify
the topology. The trees were rooted using the ancestor branches of influenza D virus
strains. C/Victoria/2/2012 strain is marked as diamond (◆).
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4.3.3 Antigenic evolution
To investigate the antigenic property of C/Vic, HI assays were performed using
polyclonal antiserum generated against 1947 C/Taylor (C/Taylor lineage) and 2012 C/Vic
(C/Sao Paulo lineage). Historical 1966 C/Johannesburg (C/JHB) (C/Aichi lineage) virus
was also included together with 1947 C/Taylor and 2012 C/Vic in this antigenic study.
Homologous HI titers for C/Taylor and C/Vic were 5120 and 1280, respectively.
Heterologous mean HI titers against C/Taylor and C/Vic antisera were normalized to
homologous C/Taylor and C/Vic titers. Interestingly, the three lineage viruses spanning
over 60 years showed equivalent cross-reactivity with C/Vic antisera with relative HI
titers 1.0 (Fig. 4.2). In contrast, cross-reactivity profile with C/Taylor antisera
discriminated three viruses clearly. Specifically, C/Taylor virus reacted most strongly
with homologous C/Taylor antisera (relative HI titer 1.0) followed by C/Vic (relative HI
titer 0.5) and by C/JHB (relative HI titer 0.25) (Fig. 4.2). These data suggested that 1947
C/Taylor was more antigenically related to 2012 C/Vic than to 1966 C/JHB. The
observed antigenic variations were in good agreement with HEF phylogeny of these ICV
strains (Fig. 4.1).
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Figure 4.2. Relative mean hemagglutination inhibition titers for 3 influenza C
viruses from triplicate data. Relative mean HI titers were calculated by normalizing
mean heterologous HI titers to mean homologous HI titers (mean heterologous HI
titer/mean homologous HI titer).

4.3.4 Structure-basis of antigenic variation
To identify critical residues of the HEF protein among these three ICVs contributing
most to the observed antigenic drift (i.e., HA titer change), pairwise comparisons of viral
HEF structures were pursued. The resolved crystal structure of C/JHB HEF (PDB ID:
1FLC) was chosen as a model template to model the HEF structures of the C/Vic and
C/Taylor strains. We focused on four secondary elements (the 170-loop, 230-helix, 270loop, and 290-loop) constituting the HEF receptor-binding pocket (RBP) for our
investigation (Fig. 4.3A). Structure modeling showed that three ICVs exhibited two
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amino acid substitutions in the 170-loop proximal to the RBP of the HEF, which likely
have a decisive role in the degree of antigenic distance observed among three ICV strains
(Fig. 4.3). Specifically, the more antigenically similar virus pair C/Vic-C/JHB or C/VicC/Taylor only had one mutation in the 170-loop. K172G or T170V substitution occurred
between C/Vic and C/JHB (Fig. 4.3B) or C/Vic and C/Taylor (Fig. 4.3C) (listed in an
arrangement as the C/Vic amino acid residue, HEF position, and C/JHB or C/Taylor
amino acid), respectively. In contrast, the more antigenically divergent virus pair
C/Taylor-C/JHB (Fig. 4.3D) acquired these two mutations V170T and K172G of the 170loop. These structure-based analyses seemed to indicate a link between the level of
antigenic variation among three strains of ICV and the number of the amino acid changes
in the proximity of the HEF receptor-binding pocket. In addition, multiple amino acid
substitutions were also identified among three viruses in various regions of the HEF
including HEF1, HEF2, and the trimeric interface. Considering that all those mutations
were distant from the RBP of the HEF protein, we speculate that these amino changes
may not modulate directly antigenicity of influenza C viruses.
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Figure 4.3. Structure-basis of antigenic variation. (A) Cartoon view of modeled HEF1
domain of C/Vic (colored Wheat), while HEF2 was colored light blue. Salic acids in
receptor binding pocket (RBP) and esterase active site (EAS) were colored cyan. Four
secondary elements (the 170-loop, 230-helix, 270-loop, and 290-loop) constituting the
HEF receptor-binding pocket were indicated with different colors. (B) (C) (D) HEF1
residues different among three virus pairs were mapped onto the modeled HEF1 domain
of C/Vic. Note the critical amino acid changes in the 170-loop of the HEF protein around
the receptor-binding pocket were highlighted by bold and underlined words.
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4.3.5 Temperature-dependent replication
To investigate whether the replication robustness of this recent ICV C/Vic isolate is
dependent on temperature and its in vitro cellular tropism, we determined the growth
kinetics of C/Vic in a panel of human, swine, and canine cell lines at the cool temperature
(33 °C) as well as at the core body temperature (37 °C). Among cell lines, MDCK cell
line is commonly used for animal and human influenza virus replication, while two
human lung epithelial cell lines A549 and Calu-3 are often employed to study the
replication of human influenza viruses. Including two swine cell lines, ST and MK1-OSU,
allowed us to determine whether human C/Vic was capable of replicating in swine cells,
especially in swine airway epithelial cells (MK1-OSU). An influenza C virus has been
previously isolated from diseased pigs and our phylogenetic analysis showed that C/Vic
is more closely related to this porcine ICV isolate C/pig/Beijing/115/81 in the two
internal genes (PB2 and M) than its human counterparts (Fig. 4.1).

As demonstrated in Fig. 4.4, C/Vic replicated more robustly at the cool temperature
(33 °C) than at the core body temperature (37 °C) in tested cell lines. This result was in
good agreement with those previously reported for other ICVs. Interestingly, the two
human airway cells lines A549 and Calu-3 showed dramatic differences in their ability to
support C/Vic replication. C/Vic reached its peak titer of 4.2 log10TCID50/ml at 33 °C and
3.7 log10TCID50/ml at 37 °C in Calu-3, respectively, while the virus only reached to 1.0
log10TCID50/ml in A549 at both 33 °C and 37 °C. The observation that these two very
similar human lung-derived cell lines behaved differently in support of C/Vic replication
is interesting. We speculate that A549 cells may lack the cellular protein(s) that is critical
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for the efficient replication of C/Vic. Alternatively, we can hypothesize that A549 cells
may produce the novel cellular inhibitor(s) that suppresses the replication of C/Vic.
Future experiments are needed to address these hypotheses. Furthermore, C/Vic was
found to replicate well in the swine cell lines ST and MK1-OSU at 33 °C. ICV was
previously isolated from pigs (Y. J. Guo et al., 1983) and shown to transmit between
human and swine (H. Kimura et al., 1997). A novel influenza D virus distantly related to
human ICV was also isolated in swine in 2011 (B. M. Hause et al., 2013). These data
seemed to suggest that C/Vic has the potential to replicate in pigs. In contrast to ST and
MK1-OSU, the third swine cell line, SD-PJEC, minimally supported C/Vic replication as
the virus was not detected at 37 °C and titers reached only 1.0 log10TCID50/ml at 33 °C at
72 and 96 hours post infection. Likewise, SD-PJEC also poorly supported human IBV
replication (Z. Sun et al., 2012). It is worth mentioning that SD-PJEC is very susceptible
to IAV infection. As such, this primary cell line can be useful to further elucidate
restriction factors that affect the replication of ICV and IBV, which will be a focus of our
future investigation.
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Figure 4.4. Growth kinetics of C/Victoria/2/2012 in different cell lines at 33 °C and
37 °C. MDCK, ST, MK1-OSU and SD-PJEC cells were infected with C/Victoria/2/2012
at an MOI of 0.01, while A549 and Calu-3 cells were infected with C/Victoria/2/2012 at
an MOI of 1.0. Viral titers were determined in MDCK cells. The results presented are the
mean values from three replicates with error bars indicated by SEM.

In summary, we have determined the genesis of a contemporary human C/Vic virus and
characterized its evolutionary pathway. We also showed that C/Vic isolate replicated
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more robustly at 33 °C than at 37 °C, which should be further investigated toward
elucidating the molecular determinants of temperature-dependent growth. Finally,
structural modeling work presented here has pinpointed two critical residues in the 170loop of the HEF protein that are likely responsible for the observed antigenic differences
among three ICV strains. The information described on this contemporary ICV here, as a
whole shall aid in the further investigation of biology, evolution, and pathogenesis of
ICV.
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